Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

Download

Total Articles

219
(from Reference Citation Analysis)

Article PDFs (4)

Cited by > 0 (154)

Searched Name

T Morisaki

Ranked By

Results Analysis

Year Published Analysis
Article Type Analysis
Publication Title Analysis
Category Analysis

Results Analysis

Indexed Articles

Year Published

Show more Refine

Article Type

Show more Refine

Article Statistics

Refine

MESH Headings

Show more Refine

First Author

Show more Refine

First Author Affiliations

Show more Refine

Authors

Show more Refine

Publication Titles

Show more Refine

Grant Agencies

Show more Refine

Countries/Regions

Show more Refine

Affiliations

Show more Refine

Corresponding Author Affiliations

Show more Refine

Category

Show more Refine

Number

Citation Analysis

Staplin N, Haynes R, Judge PK, Wanner C, Green JB, Emberson J, Preiss D, Mayne KJ, Ng SYA, Sammons E, Zhu D, Hill M, Stevens W, Wallendszus K, Brenner S, Cheung AK, Liu ZH, Li J, Hooi LS, Liu WJ, Kadowaki T, Nangaku M, Levin A, Cherney D, Maggioni AP, Pontremoli R, Deo R, Goto S, Rossello X, Tuttle KR, Steubl D, Petrini M, Seidi S, Landray MJ, Baigent C, Herrington WG, Abat S, Abd Rahman R, Abdul Cader R, Abdul Hafidz MI, Abdul Wahab MZ, Abdullah NK, Abdul-Samad T, Abe M, Abraham N, Acheampong S, Achiri P, Acosta JA, Adeleke A, Adell V, Adewuyi-Dalton R, Adnan N, Africano A, Agharazii M, Aguilar F, Aguilera A, Ahmad M, Ahmad MK, Ahmad NA, Ahmad NH, Ahmad NI, Ahmad Miswan N, Ahmad Rosdi H, Ahmed I, Ahmed S, Ahmed S, Aiello J, Aitken A, AitSadi R, Aker S, Akimoto S, Akinfolarin A, Akram S, Alberici F, Albert C, Aldrich L, Alegata M, Alexander L, Alfaress S, Alhadj Ali M, Ali A, Ali A, Alicic R, Aliu A, Almaraz R, Almasarwah R, Almeida J, Aloisi A, Al-Rabadi L, Alscher D, Alvarez P, Al-Zeer B, Amat M, Ambrose C, Ammar H, An Y, Andriaccio L, Ansu K, Apostolidi A, Arai N, Araki H, Araki S, Arbi A, Arechiga O, Armstrong S, Arnold T, Aronoff S, Arriaga W, Arroyo J, Arteaga D, Asahara S, Asai A, Asai N, Asano S, Asawa M, Asmee MF, Aucella F, Augustin M, Avery A, Awad A, Awang IY, Awazawa M, Axler A, Ayub W, Azhari Z, Baccaro R, Badin C, Bagwell B, Bahlmann-Kroll E, Bahtar AZ, Baigent C, Bains D, Bajaj H, Baker R, Baldini E, Banas B, Banerjee D, Banno S, Bansal S, Barberi S, Barnes S, Barnini C, Barot C, Barrett K, Barrios R, Bartolomei Mecatti B, Barton I, Barton J, Basily W, Bavanandan S, Baxter A, Becker L, Beddhu S, Beige J, Beigh S, Bell S, Benck U, Beneat A, Bennett A, Bennett D, Benyon S, Berdeprado J, Bergler T, Bergner A, Berry M, Bevilacqua M, Bhairoo J, Bhandari S, Bhandary N, Bhatt A, Bhattarai M, Bhavsar M, Bian W, Bianchini F, Bianco S, Bilous R, Bilton J, Bilucaglia D, Bird C, Birudaraju D, Biscoveanu M, Blake C, Bleakley N, Bocchicchia K, Bodine S, Bodington R, Boedecker S, Bolduc M, Bolton S, Bond C, Boreky F, Boren K, Bouchi R, Bough L, Bovan D, Bowler C, Bowman L, Brar N, Braun C, Breach A, Breitenfeldt M, Brenner S, Brettschneider B, Brewer A, Brewer G, Brindle V, Brioni E, Brown C, Brown H, Brown L, Brown R, Brown S, Browne D, Bruce K, Brueckmann M, Brunskill N, Bryant M, Brzoska M, Bu Y, Buckman C, Budoff M, Bullen M, Burke A, Burnette S, Burston C, Busch M, Bushnell J, Butler S, Büttner C, Byrne C, Caamano A, Cadorna J, Cafiero C, Cagle M, Cai J, Calabrese K, Calvi C, Camilleri B, Camp S, Campbell D, Campbell R, Cao H, Capelli I, Caple M, Caplin B, Cardone A, Carle J, Carnall V, Caroppo M, Carr S, Carraro G, Carson M, Casares P, Castillo C, Castro C, Caudill B, Cejka V, Ceseri M, Cham L, Chamberlain A, Chambers J, Chan CBT, Chan JYM, Chan YC, Chang E, Chang E, Chant T, Chavagnon T, Chellamuthu P, Chen F, Chen J, Chen P, Chen TM, Chen Y, Chen Y, Cheng C, Cheng H, Cheng MC, Cherney D, Cheung AK, Ching CH, Chitalia N, Choksi R, Chukwu C, Chung K, Cianciolo G, Cipressa L, Clark S, Clarke H, Clarke R, Clarke S, Cleveland B, Cole E, Coles H, Condurache L, Connor A, Convery K, Cooper A, Cooper N, Cooper Z, Cooperman L, Cosgrove L, Coutts P, Cowley A, Craik R, Cui G, Cummins T, Dahl N, Dai H, Dajani L, D'Amelio A, Damian E, Damianik K, Danel L, Daniels C, Daniels T, Darbeau S, Darius H, Dasgupta T, Davies J, Davies L, Davis A, Davis J, Davis L, Dayanandan R, Dayi S, Dayrell R, De Nicola L, Debnath S, Deeb W, Degenhardt S, DeGoursey K, Delaney M, Deo R, DeRaad R, Derebail V, Dev D, Devaux M, Dhall P, Dhillon G, Dienes J, Dobre M, Doctolero E, Dodds V, Domingo D, Donaldson D, Donaldson P, Donhauser C, Donley V, Dorestin S, Dorey S, Doulton T, Draganova D, Draxlbauer K, Driver F, Du H, Dube F, Duck T, Dugal T, Dugas J, Dukka H, Dumann H, Durham W, Dursch M, Dykas R, Easow R, Eckrich E, Eden G, Edmerson E, Edwards H, Ee LW, Eguchi J, Ehrl Y, Eichstadt K, Eid W, Eilerman B, Ejima Y, Eldon H, Ellam T, Elliott L, Ellison R, Emberson J, Epp R, Er A, Espino-Obrero M, Estcourt S, Estienne L, Evans G, Evans J, Evans S, Fabbri G, Fajardo-Moser M, Falcone C, Fani F, Faria-Shayler P, Farnia F, Farrugia D, Fechter M, Fellowes D, Feng F, Fernandez J, Ferraro P, Field A, Fikry S, Finch J, Finn H, Fioretto P, Fish R, Fleischer A, Fleming-Brown D, Fletcher L, Flora R, Foellinger C, Foligno N, Forest S, Forghani Z, Forsyth K, Fottrell-Gould D, Fox P, Frankel A, Fraser D, Frazier R, Frederick K, Freking N, French H, Froment A, Fuchs B, Fuessl L, Fujii H, Fujimoto A, Fujita A, Fujita K, Fujita Y, Fukagawa M, Fukao Y, Fukasawa A, Fuller T, Funayama T, Fung E, Furukawa M, Furukawa Y, Furusho M, Gabel S, Gaidu J, Gaiser S, Gallo K, Galloway C, Gambaro G, Gan CC, Gangemi C, Gao M, Garcia K, Garcia M, Garofalo C, Garrity M, Garza A, Gasko S, Gavrila M, Gebeyehu B, Geddes A, Gentile G, George A, George J, Gesualdo L, Ghalli F, Ghanem A, Ghate T, Ghavampour S, Ghazi A, Gherman A, Giebeln-Hudnell U, Gill B, Gillham S, Girakossyan I, Girndt M, Giuffrida A, Glenwright M, Glider T, Gloria R, Glowski D, Goh BL, Goh CB, Gohda T, Goldenberg R, Goldfaden R, Goldsmith C, Golson B, Gonce V, Gong Q, Goodenough B, Goodwin N, Goonasekera M, Gordon A, Gordon J, Gore A, Goto H, Goto S, Goto S, Gowen D, Grace A, Graham J, Grandaliano G, Gray M, Green JB, Greene T, Greenwood G, Grewal B, Grifa R, Griffin D, Griffin S, Grimmer P, Grobovaite E, Grotjahn S, Guerini A, Guest C, Gunda S, Guo B, Guo Q, Haack S, Haase M, Haaser K, Habuki K, Hadley A, Hagan S, Hagge S, Haller H, Ham S, Hamal S, Hamamoto Y, Hamano N, Hamm M, Hanburry A, Haneda M, Hanf C, Hanif W, Hansen J, Hanson L, Hantel S, Haraguchi T, Harding E, Harding T, Hardy C, Hartner C, Harun Z, Harvill L, Hasan A, Hase H, Hasegawa F, Hasegawa T, Hashimoto A, Hashimoto C, Hashimoto M, Hashimoto S, Haskett S, Hauske SJ, Hawfield A, Hayami T, Hayashi M, Hayashi S, Haynes R, Hazara A, Healy C, Hecktman J, Heine G, Henderson H, Henschel R, Hepditch A, Herfurth K, Hernandez G, Hernandez Pena A, Hernandez-Cassis C, Herrington WG, Herzog C, Hewins S, Hewitt D, Hichkad L, Higashi S, Higuchi C, Hill C, Hill L, Hill M, Himeno T, Hing A, Hirakawa Y, Hirata K, Hirota Y, Hisatake T, Hitchcock S, Hodakowski A, Hodge W, Hogan R, Hohenstatt U, Hohenstein B, Hooi L, Hope S, Hopley M, Horikawa S, Hosein D, Hosooka T, Hou L, Hou W, Howie L, Howson A, Hozak M, Htet Z, Hu X, Hu Y, Huang J, Huda N, Hudig L, Hudson A, Hugo C, Hull R, Hume L, Hundei W, Hunt N, Hunter A, Hurley S, Hurst A, Hutchinson C, Hyo T, Ibrahim FH, Ibrahim S, Ihana N, Ikeda T, Imai A, Imamine R, Inamori A, Inazawa H, Ingell J, Inomata K, Inukai Y, Ioka M, Irtiza-Ali A, Isakova T, Isari W, Iselt M, Ishiguro A, Ishihara K, Ishikawa T, Ishimoto T, Ishizuka K, Ismail R, Itano S, Ito H, Ito K, Ito M, Ito Y, Iwagaitsu S, Iwaita Y, Iwakura T, Iwamoto M, Iwasa M, Iwasaki H, Iwasaki S, Izumi K, Izumi K, Izumi T, Jaafar SM, Jackson C, Jackson Y, Jafari G, Jahangiriesmaili M, Jain N, Jansson K, Jasim H, Jeffers L, Jenkins A, Jesky M, Jesus-Silva J, Jeyarajah D, Jiang Y, Jiao X, Jimenez G, Jin B, Jin Q, Jochims J, Johns B, Johnson C, Johnson T, Jolly S, Jones L, Jones L, Jones S, Jones T, Jones V, Joseph M, Joshi S, Judge P, Junejo N, Junus S, Kachele M, Kadowaki T, Kadoya H, Kaga H, Kai H, Kajio H, Kaluza-Schilling W, Kamaruzaman L, Kamarzarian A, Kamimura Y, Kamiya H, Kamundi C, Kan T, Kanaguchi Y, Kanazawa A, Kanda E, Kanegae S, Kaneko K, Kaneko K, Kang HY, Kano T, Karim M, Karounos D, Karsan W, Kasagi R, Kashihara N, Katagiri H, Katanosaka A, Katayama A, Katayama M, Katiman E, Kato K, Kato M, Kato N, Kato S, Kato T, Kato Y, Katsuda Y, Katsuno T, Kaufeld J, Kavak Y, Kawai I, Kawai M, Kawai M, Kawase A, Kawashima S, Kazory A, Kearney J, Keith B, Kellett J, Kelley S, Kershaw M, Ketteler M, Khai Q, Khairullah Q, Khandwala H, Khoo KKL, Khwaja A, Kidokoro K, Kielstein J, Kihara M, Kimber C, Kimura S, Kinashi H, Kingston H, Kinomura M, Kinsella-Perks E, Kitagawa M, Kitajima M, Kitamura S, Kiyosue A, Kiyota M, Klauser F, Klausmann G, Kmietschak W, Knapp K, Knight C, Knoppe A, Knott C, Kobayashi M, Kobayashi R, Kobayashi T, Koch M, Kodama S, Kodani N, Kogure E, Koizumi M, Kojima H, Kojo T, Kolhe N, Komaba H, Komiya T, Komori H, Kon SP, Kondo M, Kondo M, Kong W, Konishi M, Kono K, Koshino M, Kosugi T, Kothapalli B, Kozlowski T, Kraemer B, Kraemer-Guth A, Krappe J, Kraus D, Kriatselis C, Krieger C, Krish P, Kruger B, Ku Md Razi KR, Kuan Y, Kubota S, Kuhn S, Kumar P, Kume S, Kummer I, Kumuji R, Küpper A, Kuramae T, Kurian L, Kuribayashi C, Kurien R, Kuroda E, Kurose T, Kutschat A, Kuwabara N, Kuwata H, La Manna G, Lacey M, Lafferty K, LaFleur P, Lai V, Laity E, Lambert A, Landray MJ, Langlois M, Latif F, Latore E, Laundy E, Laurienti D, Lawson A, Lay M, Leal I, Leal I, Lee AK, Lee J, Lee KQ, Lee R, Lee SA, Lee YY, Lee-Barkey Y, Leonard N, Leoncini G, Leong CM, Lerario S, Leslie A, Levin A, Lewington A, Li J, Li N, Li X, Li Y, Liberti L, Liberti ME, Liew A, Liew YF, Lilavivat U, Lim SK, Lim YS, Limon E, Lin H, Lioudaki E, Liu H, Liu J, Liu L, Liu Q, Liu WJ, Liu X, Liu Z, Loader D, Lochhead H, Loh CL, Lorimer A, Loudermilk L, Loutan J, Low CK, Low CL, Low YM, Lozon Z, Lu Y, Lucci D, Ludwig U, Luker N, Lund D, Lustig R, Lyle S, Macdonald C, MacDougall I, Machicado R, MacLean D, Macleod P, Madera A, Madore F, Maeda K, Maegawa H, Maeno S, Mafham M, Magee J, Maggioni AP, Mah DY, Mahabadi V, Maiguma M, Makita Y, Makos G, Manco L, Mangiacapra R, Manley J, Mann P, Mano S, Marcotte G, Maris J, Mark P, Markau S, Markovic M, Marshall C, Martin M, Martinez C, Martinez S, Martins G, Maruyama K, Maruyama S, Marx K, Maselli A, Masengu A, Maskill A, Masumoto S, Masutani K, Matsumoto M, Matsunaga T, Matsuoka N, Matsushita M, Matthews M, Matthias S, Matvienko E, Maurer M, Maxwell P, Mayne KJ, Mazlan N, Mazlan SA, Mbuyisa A, McCafferty K, McCarroll F, McCarthy T, McClary-Wright C, McCray K, McDermott P, McDonald C, McDougall R, McHaffie E, McIntosh K, McKinley T, McLaughlin S, McLean N, McNeil L, Measor A, Meek J, Mehta A, Mehta R, Melandri M, Mené P, Meng T, Menne J, Merritt K, Merscher S, Meshykhi C, Messa P, Messinger L, Miftari N, Miller R, Miller Y, Miller-Hodges E, Minatoguchi M, Miners M, Minutolo R, Mita T, Miura Y, Miyaji M, Miyamoto S, Miyatsuka T, Miyazaki M, Miyazawa I, Mizumachi R, Mizuno M, Moffat S, Mohamad Nor FS, Mohamad Zaini SN, Mohamed Affandi FA, Mohandas C, Mohd R, Mohd Fauzi NA, Mohd Sharif NH, Mohd Yusoff Y, Moist L, Moncada A, Montasser M, Moon A, Moran C, Morgan N, Moriarty J, Morig G, Morinaga H, Morino K, Morisaki T, Morishita Y, Morlok S, Morris A, Morris F, Mostafa S, Mostefai Y, Motegi M, Motherwell N, Motta D, Mottl A, Moys R, Mozaffari S, Muir J, Mulhern J, Mulligan S, Munakata Y, Murakami C, Murakoshi M, Murawska A, Murphy K, Murphy L, Murray S, Murtagh H, Musa MA, Mushahar L, Mustafa R, Mustafar R, Muto M, Nadar E, Nagano R, Nagasawa T, Nagashima E, Nagasu H, Nagelberg S, Nair H, Nakagawa Y, Nakahara M, Nakamura J, Nakamura R, Nakamura T, Nakaoka M, Nakashima E, Nakata J, Nakata M, Nakatani S, Nakatsuka A, Nakayama Y, Nakhoul G, Nangaku M, Naverrete G, Navivala A, Nazeer I, Negrea L, Nethaji C, Newman E, Ng SYA, Ng TJ, Ngu LLS, Nimbkar T, Nishi H, Nishi M, Nishi S, Nishida Y, Nishiyama A, Niu J, Niu P, Nobili G, Nohara N, Nojima I, Nolan J, Nosseir H, Nozawa M, Nunn M, Nunokawa S, Oda M, Oe M, Oe Y, Ogane K, Ogawa W, Ogihara T, Oguchi G, Ohsugi M, Oishi K, Okada Y, Okajyo J, Okamoto S, Okamura K, Olufuwa O, Oluyombo R, Omata A, Omori Y, Ong LM, Ong YC, Onyema J, Oomatia A, Oommen A, Oremus R, Orimo Y, Ortalda V, Osaki Y, Osawa Y, Osmond Foster J, O'Sullivan A, Otani T, Othman N, Otomo S, O'Toole J, Owen L, Ozawa T, Padiyar A, Page N, Pajak S, Paliege A, Pandey A, Pandey R, Pariani H, Park J, Parrigon M, Passauer J, Patecki M, Patel M, Patel R, Patel T, Patel Z, Paul R, Paul R, Paulsen L, Pavone L, Peixoto A, Peji J, Peng BC, Peng K, Pennino L, Pereira E, Perez E, Pergola P, Pesce F, Pessolano G, Petchey W, Petr EJ, Pfab T, Phelan P, Phillips R, Phillips T, Phipps M, Piccinni G, Pickett T, Pickworth S, Piemontese M, Pinto D, Piper J, Plummer-Morgan J, Poehler D, Polese L, Poma V, Pontremoli R, Postal A, Pötz C, Power A, Pradhan N, Pradhan R, Preiss D, Preiss E, Preston K, Prib N, Price L, Provenzano C, Pugay C, Pulido R, Putz F, Qiao Y, Quartagno R, Quashie-Akponeware M, Rabara R, Rabasa-Lhoret R, Radhakrishnan D, Radley M, Raff R, Raguwaran S, Rahbari-Oskoui F, Rahman M, Rahmat K, Ramadoss S, Ramanaidu S, Ramasamy S, Ramli R, Ramli S, Ramsey T, Rankin A, Rashidi A, Raymond L, Razali WAFA, Read K, Reiner H, Reisler A, Reith C, Renner J, Rettenmaier B, Richmond L, Rijos D, Rivera R, Rivers V, Robinson H, Rocco M, Rodriguez-Bachiller I, Rodriquez R, Roesch C, Roesch J, Rogers J, Rohnstock M, Rolfsmeier S, Roman M, Romo A, Rosati A, Rosenberg S, Ross T, Rossello X, Roura M, Roussel M, Rovner S, Roy S, Rucker S, Rump L, Ruocco M, Ruse S, Russo F, Russo M, Ryder M, Sabarai A, Saccà C, Sachson R, Sadler E, Safiee NS, Sahani M, Saillant A, Saini J, Saito C, Saito S, Sakaguchi K, Sakai M, Salim H, Salviani C, Sammons E, Sampson A, Samson F, Sandercock P, Sanguila S, Santorelli G, Santoro D, Sarabu N, Saram T, Sardell R, Sasajima H, Sasaki T, Satko S, Sato A, Sato D, Sato H, Sato H, Sato J, Sato T, Sato Y, Satoh M, Sawada K, Schanz M, Scheidemantel F, Schemmelmann M, Schettler E, Schettler V, Schlieper GR, Schmidt C, Schmidt G, Schmidt U, Schmidt-Gurtler H, Schmude M, Schneider A, Schneider I, Schneider-Danwitz C, Schomig M, Schramm T, Schreiber A, Schricker S, Schroppel B, Schulte-Kemna L, Schulz E, Schumacher B, Schuster A, Schwab A, Scolari F, Scott A, Seeger W, Seeger W, Segal M, Seifert L, Seifert M, Sekiya M, Sellars R, Seman MR, Shah S, Shah S, Shainberg L, Shanmuganathan M, Shao F, Sharma K, Sharpe C, Sheikh-Ali M, Sheldon J, Shenton C, Shepherd A, Shepperd M, Sheridan R, Sheriff Z, Shibata Y, Shigehara T, Shikata K, Shimamura K, Shimano H, Shimizu Y, Shimoda H, Shin K, Shivashankar G, Shojima N, Silva R, Sim CSB, Simmons K, Sinha S, Sitter T, Sivanandam S, Skipper M, Sloan K, Sloan L, Smith R, Smyth J, Sobande T, Sobata M, Somalanka S, Song X, Sonntag F, Sood B, Sor SY, Soufer J, Sparks H, Spatoliatore G, Spinola T, Squyres S, Srivastava A, Stanfield J, Staplin N, Staylor K, Steele A, Steen O, Steffl D, Stegbauer J, Stellbrink C, Stellbrink E, Stevens W, Stevenson A, Stewart-Ray V, Stickley J, Stoffler D, Stratmann B, Streitenberger S, Strutz F, Stubbs J, Stumpf J, Suazo N, Suchinda P, Suckling R, Sudin A, Sugamori K, Sugawara H, Sugawara K, Sugimoto D, Sugiyama H, Sugiyama H, Sugiyama T, Sullivan M, Sumi M, Suresh N, Sutton D, Suzuki H, Suzuki R, Suzuki Y, Suzuki Y, Suzuki Y, Swanson E, Swift P, Syed S, Szerlip H, Taal M, Taddeo M, Tailor C, Tajima K, Takagi M, Takahashi K, Takahashi K, Takahashi M, Takahashi T, Takahira E, Takai T, Takaoka M, Takeoka J, Takesada A, Takezawa M, Talbot M, Taliercio J, Talsania T, Tamori Y, Tamura R, Tamura Y, Tan CHH, Tan EZZ, Tanabe A, Tanabe K, Tanaka A, Tanaka A, Tanaka N, Tang S, Tang Z, Tanigaki K, Tarlac M, Tatsuzawa A, Tay JF, Tay LL, Taylor J, Taylor K, Taylor K, Te A, Tenbusch L, Teng KS, Terakawa A, Terry J, Tham ZD, Tholl S, Thomas G, Thong KM, Tietjen D, Timadjer A, Tindall H, Tipper S, Tobin K, Toda N, Tokuyama A, Tolibas M, Tomita A, Tomita T, Tomlinson J, Tonks L, Topf J, Topping S, Torp A, Torres A, Totaro F, Toth P, Toyonaga Y, Tripodi F, Trivedi K, Tropman E, Tschope D, Tse J, Tsuji K, Tsunekawa S, Tsunoda R, Tucky B, Tufail S, Tuffaha A, Turan E, Turner H, Turner J, Turner M, Tuttle KR, Tye YL, Tyler A, Tyler J, Uchi H, Uchida H, Uchida T, Uchida T, Udagawa T, Ueda S, Ueda Y, Ueki K, Ugni S, Ugwu E, Umeno R, Unekawa C, Uozumi K, Urquia K, Valleteau A, Valletta C, van Erp R, Vanhoy C, Varad V, Varma R, Varughese A, Vasquez P, Vasseur A, Veelken R, Velagapudi C, Verdel K, Vettoretti S, Vezzoli G, Vielhauer V, Viera R, Vilar E, Villaruel S, Vinall L, Vinathan J, Visnjic M, Voigt E, von-Eynatten M, Vourvou M, Wada J, Wada J, Wada T, Wada Y, Wakayama K, Wakita Y, Wallendszus K, Walters T, Wan Mohamad WH, Wang L, Wang W, Wang X, Wang X, Wang Y, Wanner C, Wanninayake S, Watada H, Watanabe K, Watanabe K, Watanabe M, Waterfall H, Watkins D, Watson S, Weaving L, Weber B, Webley Y, Webster A, Webster M, Weetman M, Wei W, Weihprecht H, Weiland L, Weinmann-Menke J, Weinreich T, Wendt R, Weng Y, Whalen M, Whalley G, Wheatley R, Wheeler A, Wheeler J, Whelton P, White K, Whitmore B, Whittaker S, Wiebel J, Wiley J, Wilkinson L, Willett M, Williams A, Williams E, Williams K, Williams T, Wilson A, Wilson P, Wincott L, Wines E, Winkelmann B, Winkler M, Winter-Goodwin B, Witczak J, Wittes J, Wittmann M, Wolf G, Wolf L, Wolfling R, Wong C, Wong E, Wong HS, Wong LW, Wong YH, Wonnacott A, Wood A, Wood L, Woodhouse H, Wooding N, Woodman A, Wren K, Wu J, Wu P, Xia S, Xiao H, Xiao X, Xie Y, Xu C, Xu Y, Xue H, Yahaya H, Yalamanchili H, Yamada A, Yamada N, Yamagata K, Yamaguchi M, Yamaji Y, Yamamoto A, Yamamoto S, Yamamoto S, Yamamoto T, Yamanaka A, Yamano T, Yamanouchi Y, Yamasaki N, Yamasaki Y, Yamasaki Y, Yamashita C, Yamauchi T, Yan Q, Yanagisawa E, Yang F, Yang L, Yano S, Yao S, Yao Y, Yarlagadda S, Yasuda Y, Yiu V, Yokoyama T, Yoshida S, Yoshidome E, Yoshikawa H, Young A, Young T, Yousif V, Yu H, Yu Y, Yuasa K, Yusof N, Zalunardo N, Zander B, Zani R, Zappulo F, Zayed M, Zemann B, Zettergren P, Zhang H, Zhang L, Zhang L, Zhang N, Zhang X, Zhao J, Zhao L, Zhao S, Zhao Z, Zhong H, Zhou N, Zhou S, Zhu D, Zhu L, Zhu S, Zietz M, Zippo M, Zirino F, Zulkipli FH. Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial. Lancet Diabetes Endocrinol 2024;12:39-50. [PMID: 38061371 PMCID: PMC7615591 DOI: 10.1016/s2213-8587(23)00321-2] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/05/2023] [Revised: 10/24/2023] [Accepted: 10/25/2023] [Indexed: 12/23/2023]

Abstract

BACKGROUND

Sodium-glucose co-transporter-2 (SGLT2) inhibitors reduce progression of chronic kidney disease and the risk of cardiovascular morbidity and mortality in a wide range of patients. However, their effects on kidney disease progression in some patients with chronic kidney disease are unclear because few clinical kidney outcomes occurred among such patients in the completed trials. In particular, some guidelines stratify their level of recommendation about who should be treated with SGLT2 inhibitors based on diabetes status and albuminuria. We aimed to assess the effects of empagliflozin on progression of chronic kidney disease both overall and among specific types of participants in the EMPA-KIDNEY trial.

METHODS

EMPA-KIDNEY, a randomised, controlled, phase 3 trial, was conducted at 241 centres in eight countries (Canada, China, Germany, Italy, Japan, Malaysia, the UK, and the USA), and included individuals aged 18 years or older with an estimated glomerular filtration rate (eGFR) of 20 to less than 45 mL/min per 1·73 m2, or with an eGFR of 45 to less than 90 mL/min per 1·73 m2 with a urinary albumin-to-creatinine ratio (uACR) of 200 mg/g or higher. We explored the effects of 10 mg oral empagliflozin once daily versus placebo on the annualised rate of change in estimated glomerular filtration rate (eGFR slope), a tertiary outcome. We studied the acute slope (from randomisation to 2 months) and chronic slope (from 2 months onwards) separately, using shared parameter models to estimate the latter. Analyses were done in all randomly assigned participants by intention to treat. EMPA-KIDNEY is registered at ClinicalTrials.gov, NCT03594110.

FINDINGS

Between May 15, 2019, and April 16, 2021, 6609 participants were randomly assigned and then followed up for a median of 2·0 years (IQR 1·5-2·4). Prespecified subgroups of eGFR included 2282 (34·5%) participants with an eGFR of less than 30 mL/min per 1·73 m2, 2928 (44·3%) with an eGFR of 30 to less than 45 mL/min per 1·73 m2, and 1399 (21·2%) with an eGFR 45 mL/min per 1·73 m2 or higher. Prespecified subgroups of uACR included 1328 (20·1%) with a uACR of less than 30 mg/g, 1864 (28·2%) with a uACR of 30 to 300 mg/g, and 3417 (51·7%) with a uACR of more than 300 mg/g. Overall, allocation to empagliflozin caused an acute 2·12 mL/min per 1·73 m2 (95% CI 1·83-2·41) reduction in eGFR, equivalent to a 6% (5-6) dip in the first 2 months. After this, it halved the chronic slope from -2·75 to -1·37 mL/min per 1·73 m2 per year (relative difference 50%, 95% CI 42-58). The absolute and relative benefits of empagliflozin on the magnitude of the chronic slope varied significantly depending on diabetes status and baseline levels of eGFR and uACR. In particular, the absolute difference in chronic slopes was lower in patients with lower baseline uACR, but because this group progressed more slowly than those with higher uACR, this translated to a larger relative difference in chronic slopes in this group (86% [36-136] reduction in the chronic slope among those with baseline uACR <30 mg/g compared with a 29% [19-38] reduction for those with baseline uACR ≥2000 mg/g; ptrend<0·0001).

INTERPRETATION

Empagliflozin slowed the rate of progression of chronic kidney disease among all types of participant in the EMPA-KIDNEY trial, including those with little albuminuria. Albuminuria alone should not be used to determine whether to treat with an SGLT2 inhibitor.

FUNDING

Boehringer Ingelheim and Eli Lilly.

Collapse

Judge PK, Staplin N, Mayne KJ, Wanner C, Green JB, Hauske SJ, Emberson JR, Preiss D, Ng SYA, Roddick AJ, Sammons E, Zhu D, Hill M, Stevens W, Wallendszus K, Brenner S, Cheung AK, Liu ZH, Li J, Hooi LS, Liu WJ, Kadowaki T, Nangaku M, Levin A, Cherney D, Maggioni AP, Pontremoli R, Deo R, Goto S, Rossello X, Tuttle KR, Steubl D, Massey D, Landray MJ, Baigent C, Haynes R, Herrington WG, Abat S, Abd Rahman R, Abdul Cader R, Abdul Hafidz MI, Abdul Wahab MZ, Abdullah NK, Abdul-Samad T, Abe M, Abraham N, Acheampong S, Achiri P, Acosta JA, Adeleke A, Adell V, Adewuyi-Dalton R, Adnan N, Africano A, Agharazii M, Aguilar F, Aguilera A, Ahmad M, Ahmad MK, Ahmad NA, Ahmad NH, Ahmad NI, Ahmad Miswan N, Ahmad Rosdi H, Ahmed I, Ahmed S, Ahmed S, Aiello J, Aitken A, AitSadi R, Aker S, Akimoto S, Akinfolarin A, Akram S, Alberici F, Albert C, Aldrich L, Alegata M, Alexander L, Alfaress S, Alhadj Ali M, Ali A, Ali A, Alicic R, Aliu A, Almaraz R, Almasarwah R, Almeida J, Aloisi A, Al-Rabadi L, Alscher D, Alvarez P, Al-Zeer B, Amat M, Ambrose C, Ammar H, An Y, Andriaccio L, Ansu K, Apostolidi A, Arai N, Araki H, Araki S, Arbi A, Arechiga O, Armstrong S, Arnold T, Aronoff S, Arriaga W, Arroyo J, Arteaga D, Asahara S, Asai A, Asai N, Asano S, Asawa M, Asmee MF, Aucella F, Augustin M, Avery A, Awad A, Awang IY, Awazawa M, Axler A, Ayub W, Azhari Z, Baccaro R, Badin C, Bagwell B, Bahlmann-Kroll E, Bahtar AZ, Baigent C, Bains D, Bajaj H, Baker R, Baldini E, Banas B, Banerjee D, Banno S, Bansal S, Barberi S, Barnes S, Barnini C, Barot C, Barrett K, Barrios R, Bartolomei Mecatti B, Barton I, Barton J, Basily W, Bavanandan S, Baxter A, Becker L, Beddhu S, Beige J, Beigh S, Bell S, Benck U, Beneat A, Bennett A, Bennett D, Benyon S, Berdeprado J, Bergler T, Bergner A, Berry M, Bevilacqua M, Bhairoo J, Bhandari S, Bhandary N, Bhatt A, Bhattarai M, Bhavsar M, Bian W, Bianchini F, Bianco S, Bilous R, Bilton J, Bilucaglia D, Bird C, Birudaraju D, Biscoveanu M, Blake C, Bleakley N, Bocchicchia K, Bodine S, Bodington R, Boedecker S, Bolduc M, Bolton S, Bond C, Boreky F, Boren K, Bouchi R, Bough L, Bovan D, Bowler C, Bowman L, Brar N, Braun C, Breach A, Breitenfeldt M, Brenner S, Brettschneider B, Brewer A, Brewer G, Brindle V, Brioni E, Brown C, Brown H, Brown L, Brown R, Brown S, Browne D, Bruce K, Brueckmann M, Brunskill N, Bryant M, Brzoska M, Bu Y, Buckman C, Budoff M, Bullen M, Burke A, Burnette S, Burston C, Busch M, Bushnell J, Butler S, Büttner C, Byrne C, Caamano A, Cadorna J, Cafiero C, Cagle M, Cai J, Calabrese K, Calvi C, Camilleri B, Camp S, Campbell D, Campbell R, Cao H, Capelli I, Caple M, Caplin B, Cardone A, Carle J, Carnall V, Caroppo M, Carr S, Carraro G, Carson M, Casares P, Castillo C, Castro C, Caudill B, Cejka V, Ceseri M, Cham L, Chamberlain A, Chambers J, Chan CBT, Chan JYM, Chan YC, Chang E, Chang E, Chant T, Chavagnon T, Chellamuthu P, Chen F, Chen J, Chen P, Chen TM, Chen Y, Chen Y, Cheng C, Cheng H, Cheng MC, Cherney D, Cheung AK, Ching CH, Chitalia N, Choksi R, Chukwu C, Chung K, Cianciolo G, Cipressa L, Clark S, Clarke H, Clarke R, Clarke S, Cleveland B, Cole E, Coles H, Condurache L, Connor A, Convery K, Cooper A, Cooper N, Cooper Z, Cooperman L, Cosgrove L, Coutts P, Cowley A, Craik R, Cui G, Cummins T, Dahl N, Dai H, Dajani L, D'Amelio A, Damian E, Damianik K, Danel L, Daniels C, Daniels T, Darbeau S, Darius H, Dasgupta T, Davies J, Davies L, Davis A, Davis J, Davis L, Dayanandan R, Dayi S, Dayrell R, De Nicola L, Debnath S, Deeb W, Degenhardt S, DeGoursey K, Delaney M, Deo R, DeRaad R, Derebail V, Dev D, Devaux M, Dhall P, Dhillon G, Dienes J, Dobre M, Doctolero E, Dodds V, Domingo D, Donaldson D, Donaldson P, Donhauser C, Donley V, Dorestin S, Dorey S, Doulton T, Draganova D, Draxlbauer K, Driver F, Du H, Dube F, Duck T, Dugal T, Dugas J, Dukka H, Dumann H, Durham W, Dursch M, Dykas R, Easow R, Eckrich E, Eden G, Edmerson E, Edwards H, Ee LW, Eguchi J, Ehrl Y, Eichstadt K, Eid W, Eilerman B, Ejima Y, Eldon H, Ellam T, Elliott L, Ellison R, Emberson J, Epp R, Er A, Espino-Obrero M, Estcourt S, Estienne L, Evans G, Evans J, Evans S, Fabbri G, Fajardo-Moser M, Falcone C, Fani F, Faria-Shayler P, Farnia F, Farrugia D, Fechter M, Fellowes D, Feng F, Fernandez J, Ferraro P, Field A, Fikry S, Finch J, Finn H, Fioretto P, Fish R, Fleischer A, Fleming-Brown D, Fletcher L, Flora R, Foellinger C, Foligno N, Forest S, Forghani Z, Forsyth K, Fottrell-Gould D, Fox P, Frankel A, Fraser D, Frazier R, Frederick K, Freking N, French H, Froment A, Fuchs B, Fuessl L, Fujii H, Fujimoto A, Fujita A, Fujita K, Fujita Y, Fukagawa M, Fukao Y, Fukasawa A, Fuller T, Funayama T, Fung E, Furukawa M, Furukawa Y, Furusho M, Gabel S, Gaidu J, Gaiser S, Gallo K, Galloway C, Gambaro G, Gan CC, Gangemi C, Gao M, Garcia K, Garcia M, Garofalo C, Garrity M, Garza A, Gasko S, Gavrila M, Gebeyehu B, Geddes A, Gentile G, George A, George J, Gesualdo L, Ghalli F, Ghanem A, Ghate T, Ghavampour S, Ghazi A, Gherman A, Giebeln-Hudnell U, Gill B, Gillham S, Girakossyan I, Girndt M, Giuffrida A, Glenwright M, Glider T, Gloria R, Glowski D, Goh BL, Goh CB, Gohda T, Goldenberg R, Goldfaden R, Goldsmith C, Golson B, Gonce V, Gong Q, Goodenough B, Goodwin N, Goonasekera M, Gordon A, Gordon J, Gore A, Goto H, Goto S, Goto S, Gowen D, Grace A, Graham J, Grandaliano G, Gray M, Green JB, Greene T, Greenwood G, Grewal B, Grifa R, Griffin D, Griffin S, Grimmer P, Grobovaite E, Grotjahn S, Guerini A, Guest C, Gunda S, Guo B, Guo Q, Haack S, Haase M, Haaser K, Habuki K, Hadley A, Hagan S, Hagge S, Haller H, Ham S, Hamal S, Hamamoto Y, Hamano N, Hamm M, Hanburry A, Haneda M, Hanf C, Hanif W, Hansen J, Hanson L, Hantel S, Haraguchi T, Harding E, Harding T, Hardy C, Hartner C, Harun Z, Harvill L, Hasan A, Hase H, Hasegawa F, Hasegawa T, Hashimoto A, Hashimoto C, Hashimoto M, Hashimoto S, Haskett S, Hauske SJ, Hawfield A, Hayami T, Hayashi M, Hayashi S, Haynes R, Hazara A, Healy C, Hecktman J, Heine G, Henderson H, Henschel R, Hepditch A, Herfurth K, Hernandez G, Hernandez Pena A, Hernandez-Cassis C, Herrington WG, Herzog C, Hewins S, Hewitt D, Hichkad L, Higashi S, Higuchi C, Hill C, Hill L, Hill M, Himeno T, Hing A, Hirakawa Y, Hirata K, Hirota Y, Hisatake T, Hitchcock S, Hodakowski A, Hodge W, Hogan R, Hohenstatt U, Hohenstein B, Hooi L, Hope S, Hopley M, Horikawa S, Hosein D, Hosooka T, Hou L, Hou W, Howie L, Howson A, Hozak M, Htet Z, Hu X, Hu Y, Huang J, Huda N, Hudig L, Hudson A, Hugo C, Hull R, Hume L, Hundei W, Hunt N, Hunter A, Hurley S, Hurst A, Hutchinson C, Hyo T, Ibrahim FH, Ibrahim S, Ihana N, Ikeda T, Imai A, Imamine R, Inamori A, Inazawa H, Ingell J, Inomata K, Inukai Y, Ioka M, Irtiza-Ali A, Isakova T, Isari W, Iselt M, Ishiguro A, Ishihara K, Ishikawa T, Ishimoto T, Ishizuka K, Ismail R, Itano S, Ito H, Ito K, Ito M, Ito Y, Iwagaitsu S, Iwaita Y, Iwakura T, Iwamoto M, Iwasa M, Iwasaki H, Iwasaki S, Izumi K, Izumi K, Izumi T, Jaafar SM, Jackson C, Jackson Y, Jafari G, Jahangiriesmaili M, Jain N, Jansson K, Jasim H, Jeffers L, Jenkins A, Jesky M, Jesus-Silva J, Jeyarajah D, Jiang Y, Jiao X, Jimenez G, Jin B, Jin Q, Jochims J, Johns B, Johnson C, Johnson T, Jolly S, Jones L, Jones L, Jones S, Jones T, Jones V, Joseph M, Joshi S, Judge P, Junejo N, Junus S, Kachele M, Kadowaki T, Kadoya H, Kaga H, Kai H, Kajio H, Kaluza-Schilling W, Kamaruzaman L, Kamarzarian A, Kamimura Y, Kamiya H, Kamundi C, Kan T, Kanaguchi Y, Kanazawa A, Kanda E, Kanegae S, Kaneko K, Kaneko K, Kang HY, Kano T, Karim M, Karounos D, Karsan W, Kasagi R, Kashihara N, Katagiri H, Katanosaka A, Katayama A, Katayama M, Katiman E, Kato K, Kato M, Kato N, Kato S, Kato T, Kato Y, Katsuda Y, Katsuno T, Kaufeld J, Kavak Y, Kawai I, Kawai M, Kawai M, Kawase A, Kawashima S, Kazory A, Kearney J, Keith B, Kellett J, Kelley S, Kershaw M, Ketteler M, Khai Q, Khairullah Q, Khandwala H, Khoo KKL, Khwaja A, Kidokoro K, Kielstein J, Kihara M, Kimber C, Kimura S, Kinashi H, Kingston H, Kinomura M, Kinsella-Perks E, Kitagawa M, Kitajima M, Kitamura S, Kiyosue A, Kiyota M, Klauser F, Klausmann G, Kmietschak W, Knapp K, Knight C, Knoppe A, Knott C, Kobayashi M, Kobayashi R, Kobayashi T, Koch M, Kodama S, Kodani N, Kogure E, Koizumi M, Kojima H, Kojo T, Kolhe N, Komaba H, Komiya T, Komori H, Kon SP, Kondo M, Kondo M, Kong W, Konishi M, Kono K, Koshino M, Kosugi T, Kothapalli B, Kozlowski T, Kraemer B, Kraemer-Guth A, Krappe J, Kraus D, Kriatselis C, Krieger C, Krish P, Kruger B, Ku Md Razi KR, Kuan Y, Kubota S, Kuhn S, Kumar P, Kume S, Kummer I, Kumuji R, Küpper A, Kuramae T, Kurian L, Kuribayashi C, Kurien R, Kuroda E, Kurose T, Kutschat A, Kuwabara N, Kuwata H, La Manna G, Lacey M, Lafferty K, LaFleur P, Lai V, Laity E, Lambert A, Landray MJ, Langlois M, Latif F, Latore E, Laundy E, Laurienti D, Lawson A, Lay M, Leal I, Leal I, Lee AK, Lee J, Lee KQ, Lee R, Lee SA, Lee YY, Lee-Barkey Y, Leonard N, Leoncini G, Leong CM, Lerario S, Leslie A, Levin A, Lewington A, Li J, Li N, Li X, Li Y, Liberti L, Liberti ME, Liew A, Liew YF, Lilavivat U, Lim SK, Lim YS, Limon E, Lin H, Lioudaki E, Liu H, Liu J, Liu L, Liu Q, Liu WJ, Liu X, Liu Z, Loader D, Lochhead H, Loh CL, Lorimer A, Loudermilk L, Loutan J, Low CK, Low CL, Low YM, Lozon Z, Lu Y, Lucci D, Ludwig U, Luker N, Lund D, Lustig R, Lyle S, Macdonald C, MacDougall I, Machicado R, MacLean D, Macleod P, Madera A, Madore F, Maeda K, Maegawa H, Maeno S, Mafham M, Magee J, Maggioni AP, Mah DY, Mahabadi V, Maiguma M, Makita Y, Makos G, Manco L, Mangiacapra R, Manley J, Mann P, Mano S, Marcotte G, Maris J, Mark P, Markau S, Markovic M, Marshall C, Martin M, Martinez C, Martinez S, Martins G, Maruyama K, Maruyama S, Marx K, Maselli A, Masengu A, Maskill A, Masumoto S, Masutani K, Matsumoto M, Matsunaga T, Matsuoka N, Matsushita M, Matthews M, Matthias S, Matvienko E, Maurer M, Maxwell P, Mayne KJ, Mazlan N, Mazlan SA, Mbuyisa A, McCafferty K, McCarroll F, McCarthy T, McClary-Wright C, McCray K, McDermott P, McDonald C, McDougall R, McHaffie E, McIntosh K, McKinley T, McLaughlin S, McLean N, McNeil L, Measor A, Meek J, Mehta A, Mehta R, Melandri M, Mené P, Meng T, Menne J, Merritt K, Merscher S, Meshykhi C, Messa P, Messinger L, Miftari N, Miller R, Miller Y, Miller-Hodges E, Minatoguchi M, Miners M, Minutolo R, Mita T, Miura Y, Miyaji M, Miyamoto S, Miyatsuka T, Miyazaki M, Miyazawa I, Mizumachi R, Mizuno M, Moffat S, Mohamad Nor FS, Mohamad Zaini SN, Mohamed Affandi FA, Mohandas C, Mohd R, Mohd Fauzi NA, Mohd Sharif NH, Mohd Yusoff Y, Moist L, Moncada A, Montasser M, Moon A, Moran C, Morgan N, Moriarty J, Morig G, Morinaga H, Morino K, Morisaki T, Morishita Y, Morlok S, Morris A, Morris F, Mostafa S, Mostefai Y, Motegi M, Motherwell N, Motta D, Mottl A, Moys R, Mozaffari S, Muir J, Mulhern J, Mulligan S, Munakata Y, Murakami C, Murakoshi M, Murawska A, Murphy K, Murphy L, Murray S, Murtagh H, Musa MA, Mushahar L, Mustafa R, Mustafar R, Muto M, Nadar E, Nagano R, Nagasawa T, Nagashima E, Nagasu H, Nagelberg S, Nair H, Nakagawa Y, Nakahara M, Nakamura J, Nakamura R, Nakamura T, Nakaoka M, Nakashima E, Nakata J, Nakata M, Nakatani S, Nakatsuka A, Nakayama Y, Nakhoul G, Nangaku M, Naverrete G, Navivala A, Nazeer I, Negrea L, Nethaji C, Newman E, Ng SYA, Ng TJ, Ngu LLS, Nimbkar T, Nishi H, Nishi M, Nishi S, Nishida Y, Nishiyama A, Niu J, Niu P, Nobili G, Nohara N, Nojima I, Nolan J, Nosseir H, Nozawa M, Nunn M, Nunokawa S, Oda M, Oe M, Oe Y, Ogane K, Ogawa W, Ogihara T, Oguchi G, Ohsugi M, Oishi K, Okada Y, Okajyo J, Okamoto S, Okamura K, Olufuwa O, Oluyombo R, Omata A, Omori Y, Ong LM, Ong YC, Onyema J, Oomatia A, Oommen A, Oremus R, Orimo Y, Ortalda V, Osaki Y, Osawa Y, Osmond Foster J, O'Sullivan A, Otani T, Othman N, Otomo S, O'Toole J, Owen L, Ozawa T, Padiyar A, Page N, Pajak S, Paliege A, Pandey A, Pandey R, Pariani H, Park J, Parrigon M, Passauer J, Patecki M, Patel M, Patel R, Patel T, Patel Z, Paul R, Paul R, Paulsen L, Pavone L, Peixoto A, Peji J, Peng BC, Peng K, Pennino L, Pereira E, Perez E, Pergola P, Pesce F, Pessolano G, Petchey W, Petr EJ, Pfab T, Phelan P, Phillips R, Phillips T, Phipps M, Piccinni G, Pickett T, Pickworth S, Piemontese M, Pinto D, Piper J, Plummer-Morgan J, Poehler D, Polese L, Poma V, Pontremoli R, Postal A, Pötz C, Power A, Pradhan N, Pradhan R, Preiss D, Preiss E, Preston K, Prib N, Price L, Provenzano C, Pugay C, Pulido R, Putz F, Qiao Y, Quartagno R, Quashie-Akponeware M, Rabara R, Rabasa-Lhoret R, Radhakrishnan D, Radley M, Raff R, Raguwaran S, Rahbari-Oskoui F, Rahman M, Rahmat K, Ramadoss S, Ramanaidu S, Ramasamy S, Ramli R, Ramli S, Ramsey T, Rankin A, Rashidi A, Raymond L, Razali WAFA, Read K, Reiner H, Reisler A, Reith C, Renner J, Rettenmaier B, Richmond L, Rijos D, Rivera R, Rivers V, Robinson H, Rocco M, Rodriguez-Bachiller I, Rodriquez R, Roesch C, Roesch J, Rogers J, Rohnstock M, Rolfsmeier S, Roman M, Romo A, Rosati A, Rosenberg S, Ross T, Rossello X, Roura M, Roussel M, Rovner S, Roy S, Rucker S, Rump L, Ruocco M, Ruse S, Russo F, Russo M, Ryder M, Sabarai A, Saccà C, Sachson R, Sadler E, Safiee NS, Sahani M, Saillant A, Saini J, Saito C, Saito S, Sakaguchi K, Sakai M, Salim H, Salviani C, Sammons E, Sampson A, Samson F, Sandercock P, Sanguila S, Santorelli G, Santoro D, Sarabu N, Saram T, Sardell R, Sasajima H, Sasaki T, Satko S, Sato A, Sato D, Sato H, Sato H, Sato J, Sato T, Sato Y, Satoh M, Sawada K, Schanz M, Scheidemantel F, Schemmelmann M, Schettler E, Schettler V, Schlieper GR, Schmidt C, Schmidt G, Schmidt U, Schmidt-Gurtler H, Schmude M, Schneider A, Schneider I, Schneider-Danwitz C, Schomig M, Schramm T, Schreiber A, Schricker S, Schroppel B, Schulte-Kemna L, Schulz E, Schumacher B, Schuster A, Schwab A, Scolari F, Scott A, Seeger W, Seeger W, Segal M, Seifert L, Seifert M, Sekiya M, Sellars R, Seman MR, Shah S, Shah S, Shainberg L, Shanmuganathan M, Shao F, Sharma K, Sharpe C, Sheikh-Ali M, Sheldon J, Shenton C, Shepherd A, Shepperd M, Sheridan R, Sheriff Z, Shibata Y, Shigehara T, Shikata K, Shimamura K, Shimano H, Shimizu Y, Shimoda H, Shin K, Shivashankar G, Shojima N, Silva R, Sim CSB, Simmons K, Sinha S, Sitter T, Sivanandam S, Skipper M, Sloan K, Sloan L, Smith R, Smyth J, Sobande T, Sobata M, Somalanka S, Song X, Sonntag F, Sood B, Sor SY, Soufer J, Sparks H, Spatoliatore G, Spinola T, Squyres S, Srivastava A, Stanfield J, Staplin N, Staylor K, Steele A, Steen O, Steffl D, Stegbauer J, Stellbrink C, Stellbrink E, Stevens W, Stevenson A, Stewart-Ray V, Stickley J, Stoffler D, Stratmann B, Streitenberger S, Strutz F, Stubbs J, Stumpf J, Suazo N, Suchinda P, Suckling R, Sudin A, Sugamori K, Sugawara H, Sugawara K, Sugimoto D, Sugiyama H, Sugiyama H, Sugiyama T, Sullivan M, Sumi M, Suresh N, Sutton D, Suzuki H, Suzuki R, Suzuki Y, Suzuki Y, Suzuki Y, Swanson E, Swift P, Syed S, Szerlip H, Taal M, Taddeo M, Tailor C, Tajima K, Takagi M, Takahashi K, Takahashi K, Takahashi M, Takahashi T, Takahira E, Takai T, Takaoka M, Takeoka J, Takesada A, Takezawa M, Talbot M, Taliercio J, Talsania T, Tamori Y, Tamura R, Tamura Y, Tan CHH, Tan EZZ, Tanabe A, Tanabe K, Tanaka A, Tanaka A, Tanaka N, Tang S, Tang Z, Tanigaki K, Tarlac M, Tatsuzawa A, Tay JF, Tay LL, Taylor J, Taylor K, Taylor K, Te A, Tenbusch L, Teng KS, Terakawa A, Terry J, Tham ZD, Tholl S, Thomas G, Thong KM, Tietjen D, Timadjer A, Tindall H, Tipper S, Tobin K, Toda N, Tokuyama A, Tolibas M, Tomita A, Tomita T, Tomlinson J, Tonks L, Topf J, Topping S, Torp A, Torres A, Totaro F, Toth P, Toyonaga Y, Tripodi F, Trivedi K, Tropman E, Tschope D, Tse J, Tsuji K, Tsunekawa S, Tsunoda R, Tucky B, Tufail S, Tuffaha A, Turan E, Turner H, Turner J, Turner M, Tuttle KR, Tye YL, Tyler A, Tyler J, Uchi H, Uchida H, Uchida T, Uchida T, Udagawa T, Ueda S, Ueda Y, Ueki K, Ugni S, Ugwu E, Umeno R, Unekawa C, Uozumi K, Urquia K, Valleteau A, Valletta C, van Erp R, Vanhoy C, Varad V, Varma R, Varughese A, Vasquez P, Vasseur A, Veelken R, Velagapudi C, Verdel K, Vettoretti S, Vezzoli G, Vielhauer V, Viera R, Vilar E, Villaruel S, Vinall L, Vinathan J, Visnjic M, Voigt E, von-Eynatten M, Vourvou M, Wada J, Wada J, Wada T, Wada Y, Wakayama K, Wakita Y, Wallendszus K, Walters T, Wan Mohamad WH, Wang L, Wang W, Wang X, Wang X, Wang Y, Wanner C, Wanninayake S, Watada H, Watanabe K, Watanabe K, Watanabe M, Waterfall H, Watkins D, Watson S, Weaving L, Weber B, Webley Y, Webster A, Webster M, Weetman M, Wei W, Weihprecht H, Weiland L, Weinmann-Menke J, Weinreich T, Wendt R, Weng Y, Whalen M, Whalley G, Wheatley R, Wheeler A, Wheeler J, Whelton P, White K, Whitmore B, Whittaker S, Wiebel J, Wiley J, Wilkinson L, Willett M, Williams A, Williams E, Williams K, Williams T, Wilson A, Wilson P, Wincott L, Wines E, Winkelmann B, Winkler M, Winter-Goodwin B, Witczak J, Wittes J, Wittmann M, Wolf G, Wolf L, Wolfling R, Wong C, Wong E, Wong HS, Wong LW, Wong YH, Wonnacott A, Wood A, Wood L, Woodhouse H, Wooding N, Woodman A, Wren K, Wu J, Wu P, Xia S, Xiao H, Xiao X, Xie Y, Xu C, Xu Y, Xue H, Yahaya H, Yalamanchili H, Yamada A, Yamada N, Yamagata K, Yamaguchi M, Yamaji Y, Yamamoto A, Yamamoto S, Yamamoto S, Yamamoto T, Yamanaka A, Yamano T, Yamanouchi Y, Yamasaki N, Yamasaki Y, Yamasaki Y, Yamashita C, Yamauchi T, Yan Q, Yanagisawa E, Yang F, Yang L, Yano S, Yao S, Yao Y, Yarlagadda S, Yasuda Y, Yiu V, Yokoyama T, Yoshida S, Yoshidome E, Yoshikawa H, Young A, Young T, Yousif V, Yu H, Yu Y, Yuasa K, Yusof N, Zalunardo N, Zander B, Zani R, Zappulo F, Zayed M, Zemann B, Zettergren P, Zhang H, Zhang L, Zhang L, Zhang N, Zhang X, Zhao J, Zhao L, Zhao S, Zhao Z, Zhong H, Zhou N, Zhou S, Zhu D, Zhu L, Zhu S, Zietz M, Zippo M, Zirino F, Zulkipli FH. Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial. Lancet Diabetes Endocrinol 2024;12:51-60. [PMID: 38061372 DOI: 10.1016/s2213-8587(23)00322-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/05/2023] [Revised: 10/24/2023] [Accepted: 10/25/2023] [Indexed: 12/23/2023]

Abstract

BACKGROUND

The EMPA-KIDNEY trial showed that empagliflozin reduced the risk of the primary composite outcome of kidney disease progression or cardiovascular death in patients with chronic kidney disease mainly through slowing progression. We aimed to assess how effects of empagliflozin might differ by primary kidney disease across its broad population.

METHODS

EMPA-KIDNEY, a randomised, controlled, phase 3 trial, was conducted at 241 centres in eight countries (Canada, China, Germany, Italy, Japan, Malaysia, the UK, and the USA). Patients were eligible if their estimated glomerular filtration rate (eGFR) was 20 to less than 45 mL/min per 1·73 m2, or 45 to less than 90 mL/min per 1·73 m2 with a urinary albumin-to-creatinine ratio (uACR) of 200 mg/g or higher at screening. They were randomly assigned (1:1) to 10 mg oral empagliflozin once daily or matching placebo. Effects on kidney disease progression (defined as a sustained ≥40% eGFR decline from randomisation, end-stage kidney disease, a sustained eGFR below 10 mL/min per 1·73 m2, or death from kidney failure) were assessed using prespecified Cox models, and eGFR slope analyses used shared parameter models. Subgroup comparisons were performed by including relevant interaction terms in models. EMPA-KIDNEY is registered with ClinicalTrials.gov, NCT03594110.

FINDINGS

Between May 15, 2019, and April 16, 2021, 6609 participants were randomly assigned and followed up for a median of 2·0 years (IQR 1·5-2·4). Prespecified subgroupings by primary kidney disease included 2057 (31·1%) participants with diabetic kidney disease, 1669 (25·3%) with glomerular disease, 1445 (21·9%) with hypertensive or renovascular disease, and 1438 (21·8%) with other or unknown causes. Kidney disease progression occurred in 384 (11·6%) of 3304 patients in the empagliflozin group and 504 (15·2%) of 3305 patients in the placebo group (hazard ratio 0·71 [95% CI 0·62-0·81]), with no evidence that the relative effect size varied significantly by primary kidney disease (pheterogeneity=0·62). The between-group difference in chronic eGFR slopes (ie, from 2 months to final follow-up) was 1·37 mL/min per 1·73 m2 per year (95% CI 1·16-1·59), representing a 50% (42-58) reduction in the rate of chronic eGFR decline. This relative effect of empagliflozin on chronic eGFR slope was similar in analyses by different primary kidney diseases, including in explorations by type of glomerular disease and diabetes (p values for heterogeneity all >0·1).

INTERPRETATION

In a broad range of patients with chronic kidney disease at risk of progression, including a wide range of non-diabetic causes of chronic kidney disease, empagliflozin reduced risk of kidney disease progression. Relative effect sizes were broadly similar irrespective of the cause of primary kidney disease, suggesting that SGLT2 inhibitors should be part of a standard of care to minimise risk of kidney failure in chronic kidney disease.

FUNDING

Boehringer Ingelheim, Eli Lilly, and UK Medical Research Council.

Collapse

Warmer F, Tanaka K, Xanthopoulos P, Nunami M, Nakata M, Beidler CD, Bozhenkov SA, Beurskens MNA, Brunner KJ, Ford OP, Fuchert G, Funaba H, Geiger J, Gradic D, Ida K, Igami H, Kubo S, Langenberg A, Laqua HP, Lazerson S, Morisaki T, Osakabe M, Pablant N, Pasch E, Peterson B, Satake S, Seki R, Shimozuma T, Smith HM, Stange T, Stechow AV, Sugama H, Suzuki Y, Takahashi H, Tokuzawa T, Tsujimura T, Turkin Y, Wolf RC, Yamada I, Yanai R, Yasuhara R, Yokoyama M, Yoshimura Y, Yoshinuma M, Zhang D. Impact of Magnetic Field Configuration on Heat Transport in Stellarators and Heliotrons. Phys Rev Lett 2021;127:225001. [PMID: 34889640 DOI: 10.1103/physrevlett.127.225001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/31/2021] [Revised: 07/30/2021] [Accepted: 09/20/2021] [Indexed: 06/13/2023]

Affiliation(s)

Felix Warmer Max-Planck-Institut für Plasmaphysik, Wendelsteinstrasse 1, 17491 Greifswald, Germany
K Tanaka National Institute for Fusion Science, National Institutes on Natural Sciences, Toki, 509-5292, Japan Kyushu University, Interdisciplinary Graduate School of Engineering Sciences, Plasma and Quantum Science and Engineering, Kasuga, Fukuoka 816-8580, Japan
P Xanthopoulos Max-Planck-Institut für Plasmaphysik, Wendelsteinstrasse 1, 17491 Greifswald, Germany
M Nunami National Institute for Fusion Science, National Institutes on Natural Sciences, Toki, 509-5292, Japan SOKENDAI (The Graduate University for Advanced Studies), Toki, Gifu 509-5292, Japan Nagoya University, Graduate School of Science, Nagoya 464-8603, Japan
M Nakata National Institute for Fusion Science, National Institutes on Natural Sciences, Toki, 509-5292, Japan SOKENDAI (The Graduate University for Advanced Studies), Toki, Gifu 509-5292, Japan
C D Beidler Max-Planck-Institut für Plasmaphysik, Wendelsteinstrasse 1, 17491 Greifswald, Germany
S A Bozhenkov Max-Planck-Institut für Plasmaphysik, Wendelsteinstrasse 1, 17491 Greifswald, Germany
M N A Beurskens Max-Planck-Institut für Plasmaphysik, Wendelsteinstrasse 1, 17491 Greifswald, Germany
K J Brunner Max-Planck-Institut für Plasmaphysik, Wendelsteinstrasse 1, 17491 Greifswald, Germany
O P Ford Max-Planck-Institut für Plasmaphysik, Wendelsteinstrasse 1, 17491 Greifswald, Germany
G Fuchert Max-Planck-Institut für Plasmaphysik, Wendelsteinstrasse 1, 17491 Greifswald, Germany
H Funaba National Institute for Fusion Science, National Institutes on Natural Sciences, Toki, 509-5292, Japan
J Geiger Max-Planck-Institut für Plasmaphysik, Wendelsteinstrasse 1, 17491 Greifswald, Germany
D Gradic Max-Planck-Institut für Plasmaphysik, Wendelsteinstrasse 1, 17491 Greifswald, Germany
K Ida National Institute for Fusion Science, National Institutes on Natural Sciences, Toki, 509-5292, Japan SOKENDAI (The Graduate University for Advanced Studies), Toki, Gifu 509-5292, Japan
H Igami National Institute for Fusion Science, National Institutes on Natural Sciences, Toki, 509-5292, Japan
S Kubo National Institute for Fusion Science, National Institutes on Natural Sciences, Toki, 509-5292, Japan Nagoya University, Graduate School of Science, Nagoya 464-8603, Japan
A Langenberg Max-Planck-Institut für Plasmaphysik, Wendelsteinstrasse 1, 17491 Greifswald, Germany
H P Laqua Max-Planck-Institut für Plasmaphysik, Wendelsteinstrasse 1, 17491 Greifswald, Germany
S Lazerson Max-Planck-Institut für Plasmaphysik, Wendelsteinstrasse 1, 17491 Greifswald, Germany
T Morisaki National Institute for Fusion Science, National Institutes on Natural Sciences, Toki, 509-5292, Japan SOKENDAI (The Graduate University for Advanced Studies), Toki, Gifu 509-5292, Japan
M Osakabe National Institute for Fusion Science, National Institutes on Natural Sciences, Toki, 509-5292, Japan SOKENDAI (The Graduate University for Advanced Studies), Toki, Gifu 509-5292, Japan
N Pablant Princeton Plasma Physics Laboratory, Princeton, New Jersey 08543, USA
E Pasch Max-Planck-Institut für Plasmaphysik, Wendelsteinstrasse 1, 17491 Greifswald, Germany
B Peterson National Institute for Fusion Science, National Institutes on Natural Sciences, Toki, 509-5292, Japan
S Satake National Institute for Fusion Science, National Institutes on Natural Sciences, Toki, 509-5292, Japan SOKENDAI (The Graduate University for Advanced Studies), Toki, Gifu 509-5292, Japan
R Seki National Institute for Fusion Science, National Institutes on Natural Sciences, Toki, 509-5292, Japan SOKENDAI (The Graduate University for Advanced Studies), Toki, Gifu 509-5292, Japan
T Shimozuma National Institute for Fusion Science, National Institutes on Natural Sciences, Toki, 509-5292, Japan
H M Smith Max-Planck-Institut für Plasmaphysik, Wendelsteinstrasse 1, 17491 Greifswald, Germany
T Stange Max-Planck-Institut für Plasmaphysik, Wendelsteinstrasse 1, 17491 Greifswald, Germany
A V Stechow Max-Planck-Institut für Plasmaphysik, Wendelsteinstrasse 1, 17491 Greifswald, Germany
H Sugama National Institute for Fusion Science, National Institutes on Natural Sciences, Toki, 509-5292, Japan SOKENDAI (The Graduate University for Advanced Studies), Toki, Gifu 509-5292, Japan
Y Suzuki National Institute for Fusion Science, National Institutes on Natural Sciences, Toki, 509-5292, Japan SOKENDAI (The Graduate University for Advanced Studies), Toki, Gifu 509-5292, Japan
H Takahashi National Institute for Fusion Science, National Institutes on Natural Sciences, Toki, 509-5292, Japan SOKENDAI (The Graduate University for Advanced Studies), Toki, Gifu 509-5292, Japan
T Tokuzawa National Institute for Fusion Science, National Institutes on Natural Sciences, Toki, 509-5292, Japan SOKENDAI (The Graduate University for Advanced Studies), Toki, Gifu 509-5292, Japan
T Tsujimura National Institute for Fusion Science, National Institutes on Natural Sciences, Toki, 509-5292, Japan SOKENDAI (The Graduate University for Advanced Studies), Toki, Gifu 509-5292, Japan
Y Turkin Max-Planck-Institut für Plasmaphysik, Wendelsteinstrasse 1, 17491 Greifswald, Germany
R C Wolf Max-Planck-Institut für Plasmaphysik, Wendelsteinstrasse 1, 17491 Greifswald, Germany
I Yamada National Institute for Fusion Science, National Institutes on Natural Sciences, Toki, 509-5292, Japan
R Yanai National Institute for Fusion Science, National Institutes on Natural Sciences, Toki, 509-5292, Japan
R Yasuhara National Institute for Fusion Science, National Institutes on Natural Sciences, Toki, 509-5292, Japan SOKENDAI (The Graduate University for Advanced Studies), Toki, Gifu 509-5292, Japan
M Yokoyama National Institute for Fusion Science, National Institutes on Natural Sciences, Toki, 509-5292, Japan SOKENDAI (The Graduate University for Advanced Studies), Toki, Gifu 509-5292, Japan
Y Yoshimura National Institute for Fusion Science, National Institutes on Natural Sciences, Toki, 509-5292, Japan
M Yoshinuma National Institute for Fusion Science, National Institutes on Natural Sciences, Toki, 509-5292, Japan SOKENDAI (The Graduate University for Advanced Studies), Toki, Gifu 509-5292, Japan
D Zhang Max-Planck-Institut für Plasmaphysik, Wendelsteinstrasse 1, 17491 Greifswald, Germany

Collapse

Saiki R, Momozawa Y, Nannya Y, Nakagawa M, Ochi Y, Yoshizato T, Terao C, Kuroda Y, Shiraishi Y, Chiba K, Tanaka H, Niida A, Imoto S, Matsuda K, Morisaki T, Murakami Y, Kamatani Y, Matsuda S, Kubo M, Miyano S, Makishima H, Ogawa S. Topic: AS04-MDS Biology and Pathogenesis/AS04a-Normal, MDS, and leukemic stem cells. Leuk Res 2021. [DOI: 10.1016/j.leukres.2021.106679.3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]

Peterson B, Kawamura G, van de Giessen P, Mukai K, Tanaka H, Sano R, Pandya S, Dai S, Masuzaki S, Akiyama T, Kobayashi M, Goto M, Motojima G, Sakamoto R, Ohno N, Morisaki T, Miyazawa J. Experimental observations and modelling of radiation asymmetries during N2 seeding in LHD. Nuclear Materials and Energy 2021. [DOI: 10.1016/j.nme.2020.100848] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]

Nespoli F, Ashikawa N, Gilson E, Lunsford R, Masuzaki S, Shoji M, Oishi T, Suzuki C, Nagy A, Mollen A, Pablant N, Ida K, Yoshinuma M, Tamura N, Gates D, Morisaki T. First impurity powder injection experiments in LHD. Nuclear Materials and Energy 2020. [DOI: 10.1016/j.nme.2020.100842] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]

Kashiwagi S, Asano Y, Kouhashi R, Ishihara S, Tauchi Y, Morisaki T, Noda S, Takashima T, Onoda N, Hirakawa K, Ohira M. Validation of the optimum timing of assessment of tumour infiltrating lymphocytes during preoperative chemotherapy for breast cancer. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz416.013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open

Asano Y, Kashiwagi S, Kouhashi R, Ishihara S, Tauchi Y, Morisaki T, Noda S, Takashima T, Onoda N, Hirakawa K, Ohira M. Verification of metabolic regulatory mechanisms in androgen receptor-positive triple negative breast cancer. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz417.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open

Motojima G, Murase T, Shoji M, Ogawa H, Yokota M, Maccallini E, Siviero F, Ferrara A, Mura M, Sakurai H, Masuzaki S, Morisaki T. New installation of in-vessel Non Evaporable Getter (NEG) pumps for the divertor pump in the LHD. Fusion Engineering and Design 2019. [DOI: 10.1016/j.fusengdes.2019.03.164] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]

Shoji M, Kawamura G, Masuzaki S, Morisaki T. Impurity transport simulation in the peripheral plasma in the large helical device with tungsten closed helical divertor. Nuclear Materials and Energy 2018. [DOI: 10.1016/j.nme.2018.11.002] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]

Takada K, Kashiwagi S, Fukui Y, Goto W, Asano Y, Morisaki T, Takashima T, Hirakawa K, Ohira M. Prognostic value of quality-of-life scores in patients with breast cancer undergoing preoperative chemotherapy. BJS Open 2018;3:38-47. [PMID: 30734014 PMCID: PMC6354182 DOI: 10.1002/bjs5.50108] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/08/2018] [Accepted: 08/24/2018] [Indexed: 11/12/2022] Open

Kashiwagi S, Asano Y, Goto W, Takada K, Takashima T, Morisaki T, Noda S, Onoda N, Hirakawa K, Ohira M. Prediction of survival after neoadjuvant chemotherapy for breast cancer by evaluation of tumor-infiltrating lymphocytes within fibrotic foci of tumor stroma (FF-TILs). Ann Oncol 2017. [DOI: 10.1093/annonc/mdx655.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open

Takada K, Kashiwagi S, Goto W, Asano Y, Takashima T, Morisaki T, Noda S, Onoda N, Hirakawa K, Ohira M. Biomarker analysis of TPD regimen (trastuzumab, ertuzumab and docetaxel) for advanced HER2-positive breast cancer by HER family expression. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx653.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open

Motojima G, Yoshida N, Masuzaki S, Sakamoto R, Tokitani M, Tanaka H, Murase T, Nagata D, Matsumoto K, Miyamoto M, Yajima M, Sakamoto M, Yamada H, Morisaki T. Wide-range evaluation of the deposition layer thickness distribution on the first wall by reflection coefficient measurements. Nuclear Materials and Energy 2017. [DOI: 10.1016/j.nme.2017.04.018] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]

Tanaka H, Kawamura G, Masuzaki S, Kobayashi M, Akiyama T, Peterson B, Mukai K, Sano R, Dai S, Sakamoto R, Morisaki T, Ohno N. Toroidally symmetric/asymmetric effect on the divertor flux due to neon/nitrogen seeding in LHD. Nuclear Materials and Energy 2017. [DOI: 10.1016/j.nme.2016.12.020] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]

Nakamura Y, Tamura N, Kobayashi M, Yoshimura S, Suzuki C, Yoshinuma M, Goto M, Motojima G, Nagaoka K, Tanaka K, Sakamoto R, Peterson B, Ida K, Osakabe M, Morisaki T. A comprehensive study on impurity behavior in LHD long pulse discharges. Nuclear Materials and Energy 2017. [DOI: 10.1016/j.nme.2016.11.005] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]

Osakabe M, Takeiri Y, Morisaki T, Motojima G, Ogawa K, Isobe M, Tanaka M, Murakami S, Shimizu A, Nagaoka K, Takahashi H, Nagasaki K, Takahashi H, Fujita T, Oya Y, Sakamoto M, Ueda Y, Akiyama T, Kasahara H, Sakakibara S, Sakamoto R, Tokitani M, Yamada H, Yokoyama M, Yoshimura Y. Current Status of Large Helical Device and Its Prospect for Deuterium Experiment. Fusion Science and Technology 2017. [DOI: 10.1080/15361055.2017.1335145] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]

Affiliation(s)

M. Osakabe National Institute for Fusion Science, Natural Institutes of Natural Sciences, 322-6 Oroshi-cho, Toki 509-5292, Japan SOKENDAI (The Graduate University for Advanced Studies), 322-6 Oroshi-cho, Toki 509-5292, Japan
Y. Takeiri National Institute for Fusion Science, Natural Institutes of Natural Sciences, 322-6 Oroshi-cho, Toki 509-5292, Japan SOKENDAI (The Graduate University for Advanced Studies), 322-6 Oroshi-cho, Toki 509-5292, Japan
T. Morisaki National Institute for Fusion Science, Natural Institutes of Natural Sciences, 322-6 Oroshi-cho, Toki 509-5292, Japan SOKENDAI (The Graduate University for Advanced Studies), 322-6 Oroshi-cho, Toki 509-5292, Japan
G. Motojima National Institute for Fusion Science, Natural Institutes of Natural Sciences, 322-6 Oroshi-cho, Toki 509-5292, Japan
K. Ogawa National Institute for Fusion Science, Natural Institutes of Natural Sciences, 322-6 Oroshi-cho, Toki 509-5292, Japan SOKENDAI (The Graduate University for Advanced Studies), 322-6 Oroshi-cho, Toki 509-5292, Japan
M. Isobe National Institute for Fusion Science, Natural Institutes of Natural Sciences, 322-6 Oroshi-cho, Toki 509-5292, Japan SOKENDAI (The Graduate University for Advanced Studies), 322-6 Oroshi-cho, Toki 509-5292, Japan
M. Tanaka National Institute for Fusion Science, Natural Institutes of Natural Sciences, 322-6 Oroshi-cho, Toki 509-5292, Japan
S. Murakami Kyoto University, Department of Mechanical Engineering and Science, Kyoto 615-8540, Japan
A. Shimizu National Institute for Fusion Science, Natural Institutes of Natural Sciences, 322-6 Oroshi-cho, Toki 509-5292, Japan
K. Nagaoka National Institute for Fusion Science, Natural Institutes of Natural Sciences, 322-6 Oroshi-cho, Toki 509-5292, Japan
H. Takahashi National Institute for Fusion Science, Natural Institutes of Natural Sciences, 322-6 Oroshi-cho, Toki 509-5292, Japan
K. Nagasaki Kyoto University, Institute of Advanced Energy, Gokasho, Uji, Kyoto 611-0011, Japan
H. Takahashi National Institute for Fusion Science, Natural Institutes of Natural Sciences, 322-6 Oroshi-cho, Toki 509-5292, Japan
T. Fujita Nagoya University, Department of Energy Engineering and Science, Graduate School of Engineering, Furo-cho, Chikusa-ku, Nagoya 464-8093, Japan
Y. Oya Shizuoka University, Radioscience Research Laboratory, Faculty of Science, 836, Ohya, Suruga-ku, Shizuoka 422-8529, Japan
M. Sakamoto University of Tsukuba, Plasma Research Center, Tsukuba, Ibaraki 305-8577, Japan
Y. Ueda Osaka University, Graduate School of Engineering, 2-1 Yamadaoka, Suita, Osaka 565-0871, Japan
T. Akiyama National Institute for Fusion Science, Natural Institutes of Natural Sciences, 322-6 Oroshi-cho, Toki 509-5292, Japan
H. Kasahara National Institute for Fusion Science, Natural Institutes of Natural Sciences, 322-6 Oroshi-cho, Toki 509-5292, Japan
S Sakakibara National Institute for Fusion Science, Natural Institutes of Natural Sciences, 322-6 Oroshi-cho, Toki 509-5292, Japan SOKENDAI (The Graduate University for Advanced Studies), 322-6 Oroshi-cho, Toki 509-5292, Japan
R. Sakamoto National Institute for Fusion Science, Natural Institutes of Natural Sciences, 322-6 Oroshi-cho, Toki 509-5292, Japan SOKENDAI (The Graduate University for Advanced Studies), 322-6 Oroshi-cho, Toki 509-5292, Japan
M. Tokitani National Institute for Fusion Science, Natural Institutes of Natural Sciences, 322-6 Oroshi-cho, Toki 509-5292, Japan
H. Yamada National Institute for Fusion Science, Natural Institutes of Natural Sciences, 322-6 Oroshi-cho, Toki 509-5292, Japan SOKENDAI (The Graduate University for Advanced Studies), 322-6 Oroshi-cho, Toki 509-5292, Japan
M. Yokoyama National Institute for Fusion Science, Natural Institutes of Natural Sciences, 322-6 Oroshi-cho, Toki 509-5292, Japan SOKENDAI (The Graduate University for Advanced Studies), 322-6 Oroshi-cho, Toki 509-5292, Japan
Y. Yoshimura National Institute for Fusion Science, Natural Institutes of Natural Sciences, 322-6 Oroshi-cho, Toki 509-5292, Japan

Collapse

Komori A, Morisaki T, Mutoh T, Sakakibara S, Takeiri Y, Kumazawa R, Kubo S, Ida K, Morita S, Narihara K, Shimozuma T, Tanaka K, Watanabe KY, Yamada H, Yoshinuma M, Akiyama T, Ashikawa N, Emoto M, Funaba H, Goto M, Ido T, Ikeda K, Inagaki S, Isobe M, Igami H, Itoh K, Kaneko O, Kawahata K, Kobuchi T, Masuzaki S, Matsuoka K, Minami T, Miyazawa J, Muto S, Nagayama Y, Nakamura Y, Nakanishi H, Narushima Y, Nishimura K, Nishiura M, Nishizawa A, Noda N, Ohdachi S, Oka Y, Osakabe M, Ohyabu N, Ozaki T, Peterson BJ, Sagara A, Saito K, Sakamoto R, Sato K, Sato M, Seki T, Shoji M, Sudo S, Tamura N, Toi K, Tokuzawa T, Tsumori K, Uda T, Watari T, Yamada I, Yokoyama M, Yoshimura Y, Motojima O, Beidler CD, Fujita T, Isayama A, Sakamoto Y, Takenaga H, Goncharov P, Ishii K, Sakamoto M, Murakami S, Notake T, Takeuchi N, Okajima S, Sasao M. Overview of Progress in LHD Experiments. Fusion Science and Technology 2017. [DOI: 10.13182/fst06-a1229] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]

Affiliation(s)

A. Komori National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
T. Morisaki National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
T. Mutoh National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
S. Sakakibara National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
Y. Takeiri National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
R. Kumazawa National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
S. Kubo National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
K. Ida National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
S. Morita National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
K. Narihara National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
T. Shimozuma National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
K. Tanaka National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
K. Y. Watanabe National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
H. Yamada National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
M. Yoshinuma National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
T. Akiyama National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
N. Ashikawa National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
M. Emoto National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
H. Funaba National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
M. Goto National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
T. Ido National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
K. Ikeda National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
S. Inagaki National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
M. Isobe National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
H. Igami National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
K. Itoh National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
O. Kaneko National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
K. Kawahata National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
T. Kobuchi National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
S. Masuzaki National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
K. Matsuoka National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
T. Minami National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
J. Miyazawa National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
S. Muto National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
Y. Nagayama National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
Y. Nakamura National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
H. Nakanishi National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
Y. Narushima National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
K. Nishimura National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
M. Nishiura National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
A. Nishizawa National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
N. Noda National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
S. Ohdachi National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
Y. Oka National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
M. Osakabe National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
N. Ohyabu National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
T. Ozaki National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
B. J. Peterson National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
A. Sagara National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
K. Saito National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
R. Sakamoto National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
K. Sato National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
M. Sato National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
T. Seki National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
M. Shoji National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
S. Sudo National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
N. Tamura National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
K. Toi National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
T. Tokuzawa National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
K. Tsumori National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
T. Uda National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
T. Watari National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
I. Yamada National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
M. Yokoyama National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
Y. Yoshimura National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
O. Motojima National Institute for Fusion Science, Toki, Gifu 509-5292, Japan
C. D. Beidler Max-Planck Institut fuer Plasmaphysik, Greifswald D-17491, Germany
T. Fujita Japan Atomic Energy Research Institute, Naka 311-0193, Japan
A. Isayama Japan Atomic Energy Research Institute, Naka 311-0193, Japan
Y. Sakamoto Japan Atomic Energy Research Institute, Naka 311-0193, Japan
H. Takenaga Japan Atomic Energy Research Institute, Naka 311-0193, Japan
P. Goncharov Graduate University for Advanced Studies, School of Mathematical and Physical Science Department of Fusion Science, Hayama 240-0193, Japan
K. Ishii Kyushu University, Research Institute for Applied Mechanics Kasuga 816-8580, Japan
M. Sakamoto Kyushu University, Research Institute for Applied Mechanics Kasuga 816-8580, Japan
S. Murakami Kyoto University, Department of Nuclear Engineering, Kyoto 606-8501, Japan
T. Notake Nagoya University, Department of Energy Engineering and Science Nagoya 464-8603, Japan
N. Takeuchi Nagoya University, Department of Energy Engineering and Science Nagoya 464-8603, Japan
S. Okajima Chubu University, Kasugai, Aichi 487-8501, Japan
M. Sasao Tohoku University, Graduate School of Engineering, Sendai 980-8579, Japan

Collapse

Yamada H, Ida K, Murakami S, Watanabe KY, Ascasibar E, Brakel R, Dinklage A, Harris JH, Okamura S, Sano F, Stroth U, Inagaki S, Tanaka K, Goto M, Nishimura K, Narihara K, Morita S, Sakakibara S, Peterson BJ, Sakamoto R, Miyazawa J, Morisaki T, Osakabe M, Toi K, Tamura N, Ikeda K, Yamazaki K, Kawahata K, Kaneko O, Ohyabu N, Komori A, Motojima O. Configuration Effect on Energy Confinement and Local Transport in LHD and Contribution to the International Stellarator Database. Fusion Science and Technology 2017. [DOI: 10.13182/fst04-a543] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]

Affiliation(s)

H. Yamada National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi Gifu-ken 509-5292, Japan
K. Ida National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi Gifu-ken 509-5292, Japan
S. Murakami Kyoto University, Department of Nuclear Engineering, Kyoto 606-8501, Japan
K. Y. Watanabe National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi Gifu-ken 509-5292, Japan
E. Ascasibar CIEMAT, 22-28040 Madrid, Spain
R. Brakel Max-Planck-Institut für Plasmaphysik, D-17941 Greifswald, Germany
A. Dinklage Max-Planck-Institut für Plasmaphysik, D-17941 Greifswald, Germany
J. H. Harris Australian National University, Plasma Research Laboratory, Canberra, ACT 0200, Australia
S. Okamura National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi Gifu-ken 509-5292, Japan
F. Sano Kyoto University, Department of Nuclear Engineering, Kyoto 606-8501, Japan
U. Stroth University of Kiel, Institute of Experimental and Applied Physics, 24098 Kiel, Germany
S. Inagaki National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi Gifu-ken 509-5292, Japan
K. Tanaka National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi Gifu-ken 509-5292, Japan
M. Goto National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi Gifu-ken 509-5292, Japan
K. Nishimura National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi Gifu-ken 509-5292, Japan
K. Narihara National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi Gifu-ken 509-5292, Japan
S. Morita National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi Gifu-ken 509-5292, Japan
S. Sakakibara National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi Gifu-ken 509-5292, Japan
B. J. Peterson National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi Gifu-ken 509-5292, Japan
R. Sakamoto National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi Gifu-ken 509-5292, Japan
J. Miyazawa
T. Morisaki National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi Gifu-ken 509-5292, Japan
M. Osakabe National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi Gifu-ken 509-5292, Japan
K. Toi National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi Gifu-ken 509-5292, Japan
N. Tamura National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi Gifu-ken 509-5292, Japan
K. Ikeda National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi Gifu-ken 509-5292, Japan
K. Yamazaki National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi Gifu-ken 509-5292, Japan
K. Kawahata National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi Gifu-ken 509-5292, Japan
O. Kaneko National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi Gifu-ken 509-5292, Japan
N. Ohyabu National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi Gifu-ken 509-5292, Japan
A. Komori National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi Gifu-ken 509-5292, Japan
O. Motojima National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi Gifu-ken 509-5292, Japan

Collapse

Shimozuma T, Yokoyama M, Ida K, Takeiri Y, Kubo S, Murakami S, Wakasa A, Idei H, Yoshimura Y, Notake T, Inagaki S, Tamura N, Toi K, Ohyabu N, Osakabe M, Ikeda K, Tsumori K, Oka Y, Nagaoka K, Kaneko O, Yamada I, Narihara K, Nagayam Y, Muto S, Tanaka K, Tokuzawa T, Morita S, Goto M, Yoshinuma M, Funaba H, Morisaki T, Watanabe KY, Miyazawa J, Mutoh T, Watari T, Ohkubo K. Improvement of Plasma Core Confinement Via Electron-Root Realization by Strongly Focused ECRH in LHD: Core Electron-Root Confinement. Fusion Science and Technology 2017. [DOI: 10.13182/fst10-a10791] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]

Affiliation(s)

T. Shimozuma National Institute for Fusion Science, Toki 509-5292, Japan
M. Yokoyama National Institute for Fusion Science, Toki 509-5292, Japan
K. Ida National Institute for Fusion Science, Toki 509-5292, Japan
Y. Takeiri National Institute for Fusion Science, Toki 509-5292, Japan
S. Kubo National Institute for Fusion Science, Toki 509-5292, Japan
S. Murakami Kyoto University, Department of Nuclear Engineering, Kyoto 606-8501, Japan
A. Wakasa Kyoto University, Department of Nuclear Engineering, Kyoto 606-8501, Japan
H. Idei Research Institute for Applied Mechanics, Kyushu University, Kasuga 816-8580, Japan
Y. Yoshimura National Institute for Fusion Science, Toki 509-5292, Japan
T. Notake RIKEN, Tera-Photonics Laboratory, Aoba Sendai-City, Miyagi 980-0845, Japan
S. Inagaki Research Institute for Applied Mechanics, Kyushu University, Kasuga 816-8580, Japan
N. Tamura Research Institute for Applied Mechanics, Kyushu University, Kasuga 816-8580, Japan
K. Toi National Institute for Fusion Science, Toki 509-5292, Japan
N. Ohyabu National Institute for Fusion Science, Toki 509-5292, Japan
M. Osakabe National Institute for Fusion Science, Toki 509-5292, Japan
K. Ikeda National Institute for Fusion Science, Toki 509-5292, Japan
K. Tsumori National Institute for Fusion Science, Toki 509-5292, Japan
Y. Oka National Institute for Fusion Science, Toki 509-5292, Japan
K. Nagaoka National Institute for Fusion Science, Toki 509-5292, Japan
O. Kaneko National Institute for Fusion Science, Toki 509-5292, Japan
I. Yamada National Institute for Fusion Science, Toki 509-5292, Japan
K. Narihara National Institute for Fusion Science, Toki 509-5292, Japan
Y. Nagayam National Institute for Fusion Science, Toki 509-5292, Japan
S. Muto National Institute for Fusion Science, Toki 509-5292, Japan
K. Tanaka National Institute for Fusion Science, Toki 509-5292, Japan
T. Tokuzawa National Institute for Fusion Science, Toki 509-5292, Japan
S. Morita National Institute for Fusion Science, Toki 509-5292, Japan
M. Goto National Institute for Fusion Science, Toki 509-5292, Japan
M. Yoshinuma National Institute for Fusion Science, Toki 509-5292, Japan
H. Funaba National Institute for Fusion Science, Toki 509-5292, Japan
T. Morisaki National Institute for Fusion Science, Toki 509-5292, Japan
K. Y. Watanabe National Institute for Fusion Science, Toki 509-5292, Japan
J. Miyazawa National Institute for Fusion Science, Toki 509-5292, Japan
T. Mutoh National Institute for Fusion Science, Toki 509-5292, Japan
T. Watari National Institute for Fusion Science, Toki 509-5292, Japan
K. Ohkubo National Institute for Fusion Science, Toki 509-5292, Japan

Collapse

Shoji M, Masuzaki S, Kobayashi M, Goto M, Morisaki T, Yamada H, Komori A, Iwamae A, Sakaue A. Investigation of the Helical Divertor Function and the Future Plan of a Closed Divertor for Efficient Particle Control in the LHD Plasma Periphery. Fusion Science and Technology 2017. [DOI: 10.13182/fst10-04] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]

Kobayashi M, Feng Y, Morita S, Masuzaki S, Ezumi N, Kobayashi T, Chowdhuri MB, Yamada H, Morisaki T, Ohyabu N, Goto M, Yamada I, Narihara K, Komori A, Motojima O. Transport Characteristics in the Stochastic Magnetic Boundary of LHD: Magnetic Field Topology and Its Impact on Divertor Physics and Impurity Transport. Fusion Science and Technology 2017. [DOI: 10.13182/fst10-a10809] [Citation(s) in RCA: 31] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]

Sakamoto R, Yamada H, Kobayashi M, Miyazawa J, Ohdachi S, Morisaki T, Masuzaki S, Goto M, Funaba H, Yamada I, Ida K, Morita S, Peterson BJ, Ohyabu N, Komori A, Motojima O. Advanced Operational Regime with Internal Diffusion Barrier on LHD. Fusion Science and Technology 2017. [DOI: 10.13182/fst10-a10793] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]

Morisaki T, Masuzaki S, Kobayashi M, Sakamoto R, Tanaka K, Narihara K, Funaba H, Feng Y, Sardei F, Ohyabu N, Komori A, Motojima O, Feng Y, Sardei F. Recent Results of LID Experiment on LHD. Fusion Science and Technology 2017. [DOI: 10.13182/fst06-a1238] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]

Morisaki T, Shoji M, Masuzaki S, Sakakibara S, Yamada H, Komori A. Flux Surface Mapping in LHD. Fusion Science and Technology 2017. [DOI: 10.13182/fst10-a10832] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]

Masuzaki S, Kobayashi M, Tokitani M, Ashikawa N, Hino T, Yamauchi Y, Nobuta Y, Yoshida N, Miyamoto M, Sakamoto R, Miyazawa J, Morisaki T, Ohyabu N, Yamada H, Komori A. Fuel Retention in LHD. Fusion Science and Technology 2017. [DOI: 10.13182/fst10-a10818] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]

Miyazawa J, Yamada H, Sakamoto R, Funaba H, Watanabe KY, Sakakibara S, Ida K, Goto M, Morisaki T, Murakami S, Inagaki S. Characteristics of the Global Energy Confinement and Central Pressure in LHD. Fusion Science and Technology 2017. [DOI: 10.13182/fst10-a10790] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]

Morisaki T, Masuzaki S, Sakamoto R, Kobayashi M, Ohyabu N, Yamada H, Komori A. Local Island Divertor Experiment. Fusion Science and Technology 2017. [DOI: 10.13182/fst10-a10810] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]

Seki T, Mutoh T, Kumazawa R, Saito K, Nakamura Y, Sakamoto M, Watanabe T, Kubo S, Shimozuma T, Yoshimura Y, Igami H, Ohkubo K, Takeiri Y, Oka Y, Tsumori K, Osakabe M, Ikeda K, Nagaoka K, Kaneko O, Miyazawa J, Morita S, Narihara K, Shoji M, Masuzaki S, Goto M, Morisaki T, Peterson BJ, Sato K, Tokuzawa T, Ashikawa N, Nishimura K, Funaba H, Chikaraishi H, Takeuchi N, Notake T, Ogawa H, Torii Y, Shimpo F, Nomura G, Yokota M, Takahashi C, Kato A, Takase Y, Kasahara H, Ichimura M, Higaki H, Zhao YP, Kwak JG, Yamada H, Kawahata K, Ohyabu N, Ida K, Nagayama Y, Noda N, Watari T, Komori A, Sudo S, Motojima O. Study of Long-Pulse Plasma Experiment Using ICRF Heating in LHD. Fusion Science and Technology 2017. [DOI: 10.13182/fst06-a1234] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]

Affiliation(s)

T. Seki National Institute for Fusion Science, Toki 509-5292, Japan
T. Mutoh National Institute for Fusion Science, Toki 509-5292, Japan
R. Kumazawa National Institute for Fusion Science, Toki 509-5292, Japan
K. Saito National Institute for Fusion Science, Toki 509-5292, Japan
Y. Nakamura National Institute for Fusion Science, Toki 509-5292, Japan
M. Sakamoto Kyushu University, Kasuga 816-8580, Japan
T. Watanabe National Institute for Fusion Science, Toki 509-5292, Japan
S. Kubo National Institute for Fusion Science, Toki 509-5292, Japan
T. Shimozuma National Institute for Fusion Science, Toki 509-5292, Japan
Y. Yoshimura National Institute for Fusion Science, Toki 509-5292, Japan
H. Igami National Institute for Fusion Science, Toki 509-5292, Japan
K. Ohkubo National Institute for Fusion Science, Toki 509-5292, Japan
Y. Takeiri National Institute for Fusion Science, Toki 509-5292, Japan
Y. Oka National Institute for Fusion Science, Toki 509-5292, Japan
K. Tsumori National Institute for Fusion Science, Toki 509-5292, Japan
M. Osakabe National Institute for Fusion Science, Toki 509-5292, Japan
K. Ikeda National Institute for Fusion Science, Toki 509-5292, Japan
K. Nagaoka National Institute for Fusion Science, Toki 509-5292, Japan
O. Kaneko National Institute for Fusion Science, Toki 509-5292, Japan
J. Miyazawa National Institute for Fusion Science, Toki 509-5292, Japan
S. Morita National Institute for Fusion Science, Toki 509-5292, Japan
K. Narihara National Institute for Fusion Science, Toki 509-5292, Japan
M. Shoji National Institute for Fusion Science, Toki 509-5292, Japan
S. Masuzaki National Institute for Fusion Science, Toki 509-5292, Japan
M. Goto National Institute for Fusion Science, Toki 509-5292, Japan
T. Morisaki National Institute for Fusion Science, Toki 509-5292, Japan
B. J. Peterson National Institute for Fusion Science, Toki 509-5292, Japan
K. Sato National Institute for Fusion Science, Toki 509-5292, Japan
T. Tokuzawa National Institute for Fusion Science, Toki 509-5292, Japan
N. Ashikawa National Institute for Fusion Science, Toki 509-5292, Japan
K. Nishimura National Institute for Fusion Science, Toki 509-5292, Japan
H. Funaba National Institute for Fusion Science, Toki 509-5292, Japan
H. Chikaraishi National Institute for Fusion Science, Toki 509-5292, Japan
N. Takeuchi Nagoya University, Faculty of Engineering, Nagoya 464-8601, Japan
T. Notake Nagoya University, Faculty of Engineering, Nagoya 464-8601, Japan
H. Ogawa Graduate University for Advanced Studies, Hayama 240-0162, Japan
Y. Torii Kyoto University, Institute of Advanced Energy, Uji 611-0011, Japan
F. Shimpo National Institute for Fusion Science, Toki 509-5292, Japan
G. Nomura National Institute for Fusion Science, Toki 509-5292, Japan
M. Yokota National Institute for Fusion Science, Toki 509-5292, Japan
C. Takahashi National Institute for Fusion Science, Toki 509-5292, Japan
A. Kato National Institute for Fusion Science, Toki 509-5292, Japan
Y. Takase University of Tokyo, Tokyo, Japan
H. Kasahara University of Tokyo, Tokyo, Japan
M. Ichimura University of Tsukuba, Tsukuba, Japan
H. Higaki University of Tsukuba, Tsukuba, Japan
Y. P. Zhao Institute of Plasma Physics, Academia Sinica, Hefei 230031, P.R. China
J. G. Kwak Korea Atomic Energy Research Institute, Daejeon 305-600, Korea Rep
H. Yamada National Institute for Fusion Science, Toki 509-5292, Japan
K. Kawahata National Institute for Fusion Science, Toki 509-5292, Japan
N. Ohyabu National Institute for Fusion Science, Toki 509-5292, Japan
K. Ida National Institute for Fusion Science, Toki 509-5292, Japan
Y. Nagayama National Institute for Fusion Science, Toki 509-5292, Japan
N. Noda National Institute for Fusion Science, Toki 509-5292, Japan
T. Watari National Institute for Fusion Science, Toki 509-5292, Japan
A. Komori National Institute for Fusion Science, Toki 509-5292, Japan
S. Sudo National Institute for Fusion Science, Toki 509-5292, Japan
O. Motojima National Institute for Fusion Science, Toki 509-5292, Japan

Collapse

König R, Grigull P, McCormick K, Feng Y, Ehmler H, Gadelmeier F, Giannone L, Hildebrandt D, Kisslinger J, Klinger T, Naujoks D, Ramasubramanian N, Renner H, Sardei F, Thomsen H, Wagner F, Wenzel U, Werner A, Komori A, Masuzaki S, Matsuoka K, Mioduszewski P, Morisaki T, Obiki T, Ohyabu N. Divertors for Helical Devices: Concepts, Plans, Results, and Problems. Fusion Science and Technology 2017. [DOI: 10.13182/fst04-a551] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]

Affiliation(s)

R. König Max-Planck-Institut für Plasmaphysik EURATOM Association, D-17491 Greifswald, Germany
P. Grigull Max-Planck-Institut für Plasmaphysik EURATOM Association, D-17491 Greifswald, Germany
K. McCormick Max-Planck-Institut für Plasmaphysik EURATOM Association, D-17491 Greifswald, Germany
Y. Feng Max-Planck-Institut für Plasmaphysik EURATOM Association, D-17491 Greifswald, Germany
H. Ehmler Max-Planck-Institut für Plasmaphysik EURATOM Association, D-17491 Greifswald, Germany
F. Gadelmeier Max-Planck-Institut für Plasmaphysik EURATOM Association, D-17491 Greifswald, Germany
L. Giannone Max-Planck-Institut für Plasmaphysik EURATOM Association, D-17491 Greifswald, Germany
D. Hildebrandt Max-Planck-Institut für Plasmaphysik EURATOM Association, D-17491 Greifswald, Germany
J. Kisslinger Max-Planck-Institut für Plasmaphysik EURATOM Association, D-17491 Greifswald, Germany
T. Klinger Max-Planck-Institut für Plasmaphysik EURATOM Association, D-17491 Greifswald, Germany
D. Naujoks Max-Planck-Institut für Plasmaphysik EURATOM Association, D-17491 Greifswald, Germany
N. Ramasubramanian Max-Planck-Institut für Plasmaphysik EURATOM Association, D-17491 Greifswald, Germany
H. Renner Max-Planck-Institut für Plasmaphysik EURATOM Association, D-17491 Greifswald, Germany
F. Sardei Max-Planck-Institut für Plasmaphysik EURATOM Association, D-17491 Greifswald, Germany
H. Thomsen Max-Planck-Institut für Plasmaphysik EURATOM Association, D-17491 Greifswald, Germany
F. Wagner Max-Planck-Institut für Plasmaphysik EURATOM Association, D-17491 Greifswald, Germany
U. Wenzel Max-Planck-Institut für Plasmaphysik EURATOM Association, D-17491 Greifswald, Germany
A. Werner Max-Planck-Institut für Plasmaphysik EURATOM Association, D-17491 Greifswald, Germany
A. Komori National Institute for Fusion Science Toki-shi, Gifu-ken 509-5292, Japan
S. Masuzaki National Institute for Fusion Science Toki-shi, Gifu-ken 509-5292, Japan
K. Matsuoka National Institute for Fusion Science Toki-shi, Gifu-ken 509-5292, Japan
P. Mioduszewski Oak Ridge National Laboratory, P.O. Box 2008, M.S. 6169, Oak Ridge, Tennessee 37831
T. Morisaki Max-Planck-Institut für Plasmaphysik EURATOM Association, D-17491 Greifswald, Germany
T. Obiki Kyoto University, Institute of Advanced Energy, Gakasho, Uji, Japan
N. Ohyabu Max-Planck-Institut für Plasmaphysik EURATOM Association, D-17491 Greifswald, Germany

Collapse

Yamada H, Kawahata K, Mutoh T, Ohyabu N, Takeiri Y, Imagawa S, Ida K, Mito T, Nagayama Y, Shimozuma T, Watanabe KY, Kobayashi M, Kumazawa R, Masuzaki S, Morisaki T, Miyazawa J, Nagaoka K, Narushima Y, Sakakibara S, Sakamoto R, Toi K, Yokoyama M, Kaneko O, Komori A, Motojima O. Progress in the Integrated Development of the Helical System. Fusion Science and Technology 2017. [DOI: 10.13182/fst10-a10789] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]

Motojima O, Yamada H, Komori A, Watanabe KY, Mutoh T, Takeiri Y, Ida K, Akiyama T, Asakura N, Ashikawa N, Chikaraishi H, Cooper WA, Emoto M, Fujita T, Fujiwara M, Funaba H, Goncharov P, Goto M, Hamada Y, Higashijima S, Hino T, Hoshino M, Ichimura M, Idei H, Ido T, Ikeda K, Imagawa S, Inagaki S, Isayama A, Isobe M, Itoh T, Itoh K, Kado S, Kalinina D, Kaneba T, Kaneko O, Kato D, Kato T, Kawahata K, Kawashima H, Kawazome H, Kobuchi T, Kondo K, Kubo S, Kumazawa R, Lyon JF, Maekawa R, Mase A, Masuzaki S, Mito T, Matsuoka K, Miura Y, Miyazawa J, More R, Morisaki T, Morita S, Murakami I, Murakami S, Mutoh S, Nagaoka K, Nagasaki K, Nagayama Y, Nakamura Y, Nakanishi H, Narihara K, Narushima Y, Nishimura H, Nishimura K, Nishiura M, Nishizawa A, Noda N, Notake T, Nozato H, Ohdachi S, Ohkubo K, Ohyabu N, Oyama N, Oka Y, Okada H, Osakabe M, Ozaki T, Peterson BJ, Sagara A, Saida T, Saito K, Sakakibara S, Sakamoto M, Sakamoto R, Sasao M, Sato K, Seki T, Shimozuma T, Shoji M, Sudo S, Takagi S, Takahashi Y, Takase Y, Takenaga H, Takeuchi N, Tamura N, Tanaka K, Tanaka M, Toi K, Takahata K, Tokuzawa T, Torii Y, Tsumori K, Watanabe F, Watanabe M, Watanabe T, Watari T, Yamada I, Yamada S, Yamaguchi T, Yamamoto S, Yamazaki K, Yanagi N, Yokoyama M, Yoshida N, Yoshimura S, Yoshimura Y, Yoshinuma M. Review on the Progress of the LHD Experiment. Fusion Science and Technology 2017. [DOI: 10.13182/fst04-a535] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]

Affiliation(s)

O. Motojima National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
H. Yamada National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
A. Komori National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
K. Y. Watanabe National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
T. Mutoh National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
Y. Takeiri National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
K. Ida National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
T. Akiyama National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
N. Asakura National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
N. Ashikawa National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
H. Chikaraishi National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
W. A. Cooper National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
M. Emoto National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
T. Fujita National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
M. Fujiwara National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
H. Funaba National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
P. Goncharov National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
M. Goto National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
Y. Hamada National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
S. Higashijima National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
T. Hino National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
M. Hoshino National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
M. Ichimura National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
H. Idei National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
T. Ido National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
K. Ikeda National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
S. Imagawa National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
S. Inagaki National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
A. Isayama National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
M. Isobe National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
T. Itoh National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
K. Itoh National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
S. Kado National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
D. Kalinina National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
T. Kaneba National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
O. Kaneko National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
D. Kato National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
T. Kato National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
K. Kawahata National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
H. Kawashima National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
H. Kawazome National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
T. Kobuchi National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
K. Kondo National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
S. Kubo National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
R. Kumazawa National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
J. F. Lyon National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
R. Maekawa National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
A. Mase National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
S. Masuzaki National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
T. Mito National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
K. Matsuoka National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
Y. Miura National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
J. Miyazawa National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
R. More National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
T. Morisaki National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
S. Morita National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
I. Murakami National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
S. Murakami National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
S. Mutoh National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
K. Nagaoka National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
K. Nagasaki National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
Y. Nagayama National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
Y. Nakamura National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
H. Nakanishi National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
K. Narihara National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
Y. Narushima National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
H. Nishimura National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
K. Nishimura National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
M. Nishiura National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
A. Nishizawa National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
N. Noda National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
T. Notake National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
H. Nozato National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
S. Ohdachi National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
K. Ohkubo National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
N. Ohyabu National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
N. Oyama National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
Y. Oka National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
H. Okada National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
M. Osakabe National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
T. Ozaki National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
B. J. Peterson National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
A. Sagara National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
T. Saida National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
K. Saito National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
S. Sakakibara National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
M. Sakamoto National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
R. Sakamoto National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
M. Sasao National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
K. Sato National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
T. Seki National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
T. Shimozuma National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
M. Shoji National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
S. Sudo National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
S. Takagi National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
Y. Takahashi National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
Y. Takase National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
H. Takenaga National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
N. Takeuchi National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
N. Tamura National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
K. Tanaka National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
M. Tanaka National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
K. Toi National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
K. Takahata National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
T. Tokuzawa National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
Y. Torii National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
K. Tsumori National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
F. Watanabe National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
M. Watanabe National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
T. Watanabe National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
T. Watari National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
I. Yamada National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
S. Yamada National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
T. Yamaguchi National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
S. Yamamoto National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
K. Yamazaki National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
N. Yanagi National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
M. Yokoyama National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
N. Yoshida National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
S. Yoshimura National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
Y. Yoshimura National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan
M. Yoshinuma National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi, Gifu-ken 509-5292, Japan

Collapse

Masuzaki S, Morisaki T, Shoji M, Kubota Y, Watanabe T, Kobayashi M, Miyazawa J, Goto M, Morita S, Peterson BJ, Ohyabu N, Komori A, Motojima O, Ogawa H. Overview and Future Plan of Helical Divertor Study in the Large Helical Device. Fusion Science and Technology 2017. [DOI: 10.13182/fst06-a1257] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]

Goto W, Kashiwagi S, Asano Y, Takada K, Takashima T, Morisaki T, Noda S, Onoda N, Ohsawa M, Hirakawa K, Ohira M. Abstract P6-09-25: Circulating tumor cell clusters-associated gene plakoglobin is a novel prognostic predictor in patients with breast cancer. Cancer Res 2017. [DOI: 10.1158/1538-7445.sabcs16-p6-09-25] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]

Abstract Abstract Background: Accumulating evidence shows that circulating tumor cells (CTC) are linked to metastatic relapse and are regarded as a prognostic marker for human cancer. It was reported that CTC clusters (CTCc) have more metastatic potential than single CTC. Lately, studies also show that the high expression of plakoglobin, a cell adhesion protein, within the primary tumor are positively associated with CTCc in breast cancer patients. In addition, it is thought that insufficient expression of plakoglobin could promote epithelial-mesenchymal transition (EMT). In this study, we investigated the correlation between plakoglobin expression and survival of breast cancer. Materials and Methods:A total of 126 patients with resectable early-stage breast cancer were treated with neoadjuvant chemotherapy (NAC). All patients received a standardized protocol of NAC consisting of four courses of FEC100 (500 mg/m2 fluorouracil, 100 mg/m2 epirubicin, and 500 mg/m2 cyclophosphamide) every 3 weeks, followed by 12 courses of 80 mg/m2 paclitaxel administered weekly. The expression of plakoglobin were identified by immunohistochemical staining properties in cell membrane. Staining with plakoglobin (clone 4C12) was scored according to the percentage of cells that stained positively: low, 0-25%; medium, 26-75%; high, >75%. We investigated the correlation between the plakoglobin expression in primary tumor specimen and clinical outcomes including overall-survival (OS), disease-free-survival (DFS), distant-metastasis-free-survival (DMFS), the efficacy of NAC. And we examined the relation between the expression of plakoglobin and E-cadherin, EMT marker. Results: The patient with high plakoglobin expression had significantly worse OS (p=0.021, log-rank) and DFS (p=0.015, log-rank), DMFS (p=0.040, log-rank). And the plakoglobin expression had no correlation with pathological complete response (pCR) rate (p=0.596). Also, there was not a statistically significant relationship between the plakoglobin expression and other clinicopathological parameters including tumor size (p=0.708), lymph node status (p=0.479), subtype (p=0.413), nuclear grade (p=0.642), Ki67 (p=0.202), tumor infiltrating lymphocytes (p=0.828). On univariate analysis with respect to distal metastasis, high plakoglobin expression showed worse prognosis than low plakoglobin expression (p=0.013, hazard ratio=4.221). And multivariate analysis found the same result (p=0.015, hazard ratio=4.070). In addition, there was a significant relationship between the expression of plakoglobin and E-cadherin (p=0.023). Conclusions: Plakoglobin expression is an independent prognostic factor in the patients with breast cancer; particularly for DMFS, and this mechanism related to EMT.Background: Accumulating evidence shows that circulating tumor cells (CTC) are linked to metastatic relapse and are regarded as a prognostic marker for human cancer. It was reported that CTC clusters (CTCc) have more metastatic potential than single CTC. Lately, studies also show that the high expression of plakoglobin, a cell adhesion protein, within the primary tumor are positively associated with CTCc in breast cancer patients. In addition, it is thought that insufficient expression of plakoglobin could promote epithelial-mesenchymal transition (EMT). In this study, we investigated the correlation between plakoglobin expression and survival of breast cancer. Materials and Methods:A total of 126 patients with resectable early-stage breast cancer were treated with neoadjuvant chemotherapy (NAC). All patients received a standardized protocol of NAC consisting of four courses of FEC100 (500 mg/m2 fluorouracil, 100 mg/m2 epirubicin, and 500 mg/m2 cyclophosphamide) every 3 weeks, followed by 12 courses of 80 mg/m2 paclitaxel administered weekly. The expression of plakoglobin were identified by immunohistochemical staining properties in cell membrane. Staining with plakoglobin (clone 4C12) was scored according to the percentage of cells that stained positively: low, 0-25%; medium, 26-75%; high, >75%. We investigated the correlation between the plakoglobin expression in primary tumor specimen and clinical outcomes including overall-survival (OS), disease-free-survival (DFS), distant-metastasis-free-survival (DMFS), the efficacy of NAC. And we examined the relation between the expression of plakoglobin and E-cadherin, EMT marker. Results: The patient with high plakoglobin expression had significantly worse OS (p=0.021, log-rank) and DFS (p=0.015, log-rank), DMFS (p=0.040, log-rank). And the plakoglobin expression had no correlation with pathological complete response (pCR) rate (p=0.596). Also, there was not a statistically significant relationship between the plakoglobin expression and other clinicopathological parameters including tumor size (p=0.708), lymph node status (p=0.479), subtype (p=0.413), nuclear grade (p=0.642), Ki67 (p=0.202), tumor infiltrating lymphocytes (p=0.828). On univariate analysis with respect to distal metastasis, high plakoglobin expression showed worse prognosis than low plakoglobin expression (p=0.013, hazard ratio=4.221). And multivariate analysis found the same result (p=0.015, hazard ratio=4.070). In addition, there was a significant relationship between the expression of plakoglobin and E-cadherin (p=0.023). Conclusions: Plakoglobin expression is an independent prognostic factor in the patients with breast cancer; particularly for DMFS, and this mechanism related to EMT. Citation Format: Goto W, Kashiwagi S, Asano Y, Takada K, Takashima T, Morisaki T, Noda S, Onoda N, Ohsawa M, Hirakawa K, Ohira M. Circulating tumor cell clusters-associated gene plakoglobin is a novel prognostic predictor in patients with breast cancer [abstract]. In: Proceedings of the 2016 San Antonio Breast Cancer Symposium; 2016 Dec 6-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2017;77(4 Suppl):Abstract nr P6-09-25. Collapse

Kashiwagi S, Asano Y, Goto W, Takada K, Takashima T, Morisaki T, Noda S, Onoda N, Ohsawa M, Hirakawa K, Ohira M. Abstract P3-04-20: Predicting therapeutic effect by on tumor invasion lymphocytes (TILs) in endocrine therapy for stage IV breast cancer. Cancer Res 2017. [DOI: 10.1158/1538-7445.sabcs16-p3-04-20] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]

Abstract Abstract Background: Breast cancer with distant metastasis at first presentation (stage IV disease) is often encountered in the outpatient department. With recent advances in multimodal therapies for breast cancer, long-term survival can now be expected even in stage IV breast cancer with distant metastasis. However, a goal in treating metastatic disease is prolongation of survival while maintaining good quality of life (QOL). Endocrine therapy is suitable for this purpose.The tumor immune environment not only modulates the effects of immunotherapy, but also the effects of other anticancer drugs and treatment outcomes. These immune responses can be evaluated with tumor-infiltrating lymphocytes (TILs), which has frequently been verified clinically. In the present study, we hypothesized that TILs would be useful as predictive marker of the therapeutic effect in endocrine therapy as well. In this study, the prediction of the therapeutic effect by TILs in endocrine therapy for stage IV breast cancer was clinically verified. Materials and Methods:Data from 40 patients who underwent endocrine therapy as the initial drug therapy for stage IV breast cancer were used. The correlation between TILs evaluated according to the standard method, and prognosis, including the efficacy of endocrine therapy, was investigated retrospectively. Patients with 350% lymphocytic infiltration were considered to have lymphocyte-predominant breast cancer (LPBC). Results:Among all 40 patients, TIL levels were high in 13 (32.5%) and low in 27 (67.5%) patients. Nine patients (22.5%) had LPBC, and 31 patients (77.5%) had non-LPBC. Investigation of the clinical pathological features of patients showed no significant differences between the high TIL and low TIL groups. There were also no significant differences between LPBC and non-LPBC patients. An analysis of outcomes comparing the high TIL and low TIL groups showed no prolongation in progression-free survival (PFS) (p=0.171, log-rank), time to treatment failure (TTF)(p=0.054), or overall survival (OS) (p=0.641). LPBC patients had significant prolongations of PFS (p=0.005), TTF (p=0.001), and OS (p=0.027) compared to non-LPBC patients. On receiver operating characteristic (ROC) curve analyses, results were better with LPBC (AUC: 0.700) than with TILs (AUC: 0.606). Conclusion: The present findings suggest that a high level of lymphocytic infiltration in the tumor stroma may serve as a predictor of the therapeutic effect of endocrine therapy for patients with stage IV ER-positive breast cancer. Citation Format: Kashiwagi S, Asano Y, Goto W, Takada K, Takashima T, Morisaki T, Noda S, Onoda N, Ohsawa M, Hirakawa K, Ohira M. Predicting therapeutic effect by on tumor invasion lymphocytes (TILs) in endocrine therapy for stage IV breast cancer [abstract]. In: Proceedings of the 2016 San Antonio Breast Cancer Symposium; 2016 Dec 6-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2017;77(4 Suppl):Abstract nr P3-04-20. Collapse

Affiliation(s)

S Kashiwagi Osaka City University Graduate School of Medicine, Osaka, Japan; Deaprtment of Diagnostic Pathology, Osaka City University Graduate School of Medicine, Osaka, Japan
Y Asano Osaka City University Graduate School of Medicine, Osaka, Japan; Deaprtment of Diagnostic Pathology, Osaka City University Graduate School of Medicine, Osaka, Japan
W Goto Osaka City University Graduate School of Medicine, Osaka, Japan; Deaprtment of Diagnostic Pathology, Osaka City University Graduate School of Medicine, Osaka, Japan
K Takada Osaka City University Graduate School of Medicine, Osaka, Japan; Deaprtment of Diagnostic Pathology, Osaka City University Graduate School of Medicine, Osaka, Japan
T Takashima Osaka City University Graduate School of Medicine, Osaka, Japan; Deaprtment of Diagnostic Pathology, Osaka City University Graduate School of Medicine, Osaka, Japan
T Morisaki Osaka City University Graduate School of Medicine, Osaka, Japan; Deaprtment of Diagnostic Pathology, Osaka City University Graduate School of Medicine, Osaka, Japan
S Noda Osaka City University Graduate School of Medicine, Osaka, Japan; Deaprtment of Diagnostic Pathology, Osaka City University Graduate School of Medicine, Osaka, Japan
N Onoda Osaka City University Graduate School of Medicine, Osaka, Japan; Deaprtment of Diagnostic Pathology, Osaka City University Graduate School of Medicine, Osaka, Japan
M Ohsawa Osaka City University Graduate School of Medicine, Osaka, Japan; Deaprtment of Diagnostic Pathology, Osaka City University Graduate School of Medicine, Osaka, Japan
K Hirakawa Osaka City University Graduate School of Medicine, Osaka, Japan; Deaprtment of Diagnostic Pathology, Osaka City University Graduate School of Medicine, Osaka, Japan
M Ohira Osaka City University Graduate School of Medicine, Osaka, Japan; Deaprtment of Diagnostic Pathology, Osaka City University Graduate School of Medicine, Osaka, Japan

Collapse

Asano Y, Kashiwagi S, Goto W, Takada K, Takashima T, Morisaki T, Noda S, Onoda N, Ohsawa M, Hirakawa K, Ohira M. Abstract P2-05-05: Prediction of survival after neoadjuvant chemotherapy for breast cancer by evaluation of tumor-infiltrating lymphocytes (TILs) and residual cancer burden (RCB). Cancer Res 2017. [DOI: 10.1158/1538-7445.sabcs16-p2-05-05] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]

Abstract Abstract Background: The tumor immune environment not only modulates the effects of immunotherapy, but also the effects of other anticancer drugs and treatment outcomes. Thus, the importance of inhibiting and improving the tumor immune microenvironment is now recognized. These immune responses can be evaluated with tumor-infiltrating lymphocytes (TILs), which has frequently been verified clinically. On the other hand, residual cancer burden (RCB) evaluation has been shown to be a useful predictor of survival after neoadjuvant chemotherapy (NAC). In this study, RCB and TILs evaluations were combined to produce an indicator that we have termed “RCB-TILs”, and its clinical application to NAC for breast cancer was verified by subtype-stratified analysis. Materials and Methods:A total of 177 patients with resectable early-stage breast cancer were treated with NAC.The correlation between TILs evaluated according to the standard method, and prognosis, including the efficacy of NAC, was investigated retrospectively. The RCB was calculated using the Residual Cancer Burden Calculator on the website of the MD Anderson Cancer Center. The RCB and TILs evaluations were combined to create the “RCB-TILs”. Patients who were RCB-positive and had high TILs were considered RCB-TILs-positive, and all other combinations were RCB-TILs-negative. Results: Univariable analysis of patients with high TILs found that this contributed significantly to prolonging DFS in all patients (p = 0.022, hazard ratio = 0.420), TNBC patients (p = 0.004, hazard ratio = 0.177), and HER2BC patients (p = 0.026, hazard ratio = 0.123). For HRBC patients, however, high TILs did not contribute to survival (p = 0.990, hazard ratio = 0.992). Being RCB-TILs-positive, however, contributed significantly to prolonging DFS in all patients (p < 0.001, hazard ratio = 0.181), TNBC patients (p < 0.001, hazard ratio = 0.099), HER2BC patients (p = 0.026, hazard ratio = 0.123), and HRBC patients (p = 0.039, hazard ratio = 0.258). On multivariable analysis, being RCB-TILs-positive was an independent factor for recurrence after NAC in all patients (p < 0.001, hazard ratio = 0.048), TNBC patients (p = 0.018, hazard ratio = 0.041), HER2BC patients (p = 0.036, hazard ratio = 0.134), and HRBC patients (p = 0.002, hazard ratio = 0.081). Conclusion: The results of the present study suggest that RCB-TILs is a significant predictor for breast cancer recurrence after NAC and may be a more sensitive indicator than TILs alone. Citation Format: Asano Y, Kashiwagi S, Goto W, Takada K, Takashima T, Morisaki T, Noda S, Onoda N, Ohsawa M, Hirakawa K, Ohira M. Prediction of survival after neoadjuvant chemotherapy for breast cancer by evaluation of tumor-infiltrating lymphocytes (TILs) and residual cancer burden (RCB) [abstract]. In: Proceedings of the 2016 San Antonio Breast Cancer Symposium; 2016 Dec 6-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2017;77(4 Suppl):Abstract nr P2-05-05. Collapse

Affiliation(s)

Y Asano Osaka City University Graduate School of Medicine, Osaka, Japan; Deaprtment of Diagnostic Pathology, Osaka City University Graduate School of Medicine, Osaka, Japan
S Kashiwagi Osaka City University Graduate School of Medicine, Osaka, Japan; Deaprtment of Diagnostic Pathology, Osaka City University Graduate School of Medicine, Osaka, Japan
W Goto Osaka City University Graduate School of Medicine, Osaka, Japan; Deaprtment of Diagnostic Pathology, Osaka City University Graduate School of Medicine, Osaka, Japan
K Takada Osaka City University Graduate School of Medicine, Osaka, Japan; Deaprtment of Diagnostic Pathology, Osaka City University Graduate School of Medicine, Osaka, Japan
T Takashima Osaka City University Graduate School of Medicine, Osaka, Japan; Deaprtment of Diagnostic Pathology, Osaka City University Graduate School of Medicine, Osaka, Japan
T Morisaki Osaka City University Graduate School of Medicine, Osaka, Japan; Deaprtment of Diagnostic Pathology, Osaka City University Graduate School of Medicine, Osaka, Japan
S Noda Osaka City University Graduate School of Medicine, Osaka, Japan; Deaprtment of Diagnostic Pathology, Osaka City University Graduate School of Medicine, Osaka, Japan
N Onoda Osaka City University Graduate School of Medicine, Osaka, Japan; Deaprtment of Diagnostic Pathology, Osaka City University Graduate School of Medicine, Osaka, Japan
M Ohsawa Osaka City University Graduate School of Medicine, Osaka, Japan; Deaprtment of Diagnostic Pathology, Osaka City University Graduate School of Medicine, Osaka, Japan
K Hirakawa Osaka City University Graduate School of Medicine, Osaka, Japan; Deaprtment of Diagnostic Pathology, Osaka City University Graduate School of Medicine, Osaka, Japan
M Ohira Osaka City University Graduate School of Medicine, Osaka, Japan; Deaprtment of Diagnostic Pathology, Osaka City University Graduate School of Medicine, Osaka, Japan

Collapse

Kashiwagi S, Asano Y, Goto W, Morisaki T, Noda S, Takashima T, Onoda N, Hirakawa K. Abstract P3-07-33: Prediction of the treatment response to neoadjuvant chemotherapy in breast cancer by subtypes using tumor-infiltrating lymphocytes. Cancer Res 2016. [DOI: 10.1158/1538-7445.sabcs15-p3-07-33] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]

Abstract Abstract Purpose: Monitoring the host immunological response to cancer in the microenvironment of the interaction between tumor and the body plays an important role in predicting treatment response and outcomes. Recent interest has focused on the morphological evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer (BC) and on the evidence showing their clinical relevance. Meanwhile, no consensus has yet been reached on standard methods for pathological evaluation of TILs. Therefore, methods of evaluation have differed in reports to date showing the clinical relevance of TILs. An International Working Group (2014) announced recommendations for evaluating TILs in an effort to improve consistency and reproducibility. In this study, the clinical validity and utility of TILs in NAC were investigated based on this recommendation with a stratified analysis by BC subtypes. Changes in TILs after recurrence, which have seldom been reported to date, are also discussed. Experimental Design: TILs was evaluated in 177 patients with breast cancer treated with NAC and subsequent curative surgery. All patients received a standardized protocol of NAC consisting of four courses of FEC100 (500 mg/m2 fluorouracil, 100 mg/m2 epirubicin, and 500 mg/m2 cyclophosphamide) every 3 weeks, followed by 12 courses of 80 mg/m2 paclitaxel administered weekly. Forty-five patients had HER2-positive breast cancer and were additionally administered weekly (2 mg/kg) or tri-weekly (6 mg/kg) trastuzumab during paclitaxel treatment. The correlation between TILs evaluated according to the standard method, and prognosis, including the efficacy of NAC, was investigated retrospectively. Results: In the 96 high-TIL group, compared to the 81 low-TIL group, triple-negative breast cancer (TNBC) (p < 0.001) and HER2-enriched (p = 0.040) were significantly more frequent, and the pathological complete response (pCR) rate were significantly higher (p = 0.003). On multivariate analysis also demonstrated that high-TIL status was an independent factor to indicate significantly more favorable prognosis of the patients compared with low-TIL status (p = 0.036, HR = 0.45). Among the 61 TNBC and the 36 HER2-enriched patients, the pCR rate was significantly higher in the high-TIL group than in the low-TIL group (p = 0.013) (p = 0.014). On multivariate analysis also showed that high-TIL status was an independent factor to predict the favorable prognosis (p = 0.023, HR = 0.24) (p = 0.036, HR = 0.13). Biopsy specimens from local recurrence after successful NAC frequently showed decreased TILs. Conclusion: TILs may be a biomarker to predict treatment response to NAC in patients with TNBC and HER2-enriched subtypes of BC. A decrease in TILs may also be associated with tumor recurrence. Citation Format: Kashiwagi S, Asano Y, Goto W, Morisaki T, Noda S, Takashima T, Onoda N, Hirakawa K. Prediction of the treatment response to neoadjuvant chemotherapy in breast cancer by subtypes using tumor-infiltrating lymphocytes. [abstract]. In: Proceedings of the Thirty-Eighth Annual CTRC-AACR San Antonio Breast Cancer Symposium: 2015 Dec 8-12; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2016;76(4 Suppl):Abstract nr P3-07-33. Collapse

Asano Y, Kashiwagi S, Goto W, Morisaki T, Noda S, Takashima T, Onoda N, Hirakawa K. Abstract P4-04-14: Prediction of treatment responses to neoadjuvant chemotherapy in triple-negative breast cancer by analysis of immune checkpoint protein expression. Cancer Res 2016. [DOI: 10.1158/1538-7445.sabcs15-p4-04-14] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]

Abstract Abstract Purpose: "Avoiding immune destruction" has recently been established as one of the hallmarks of cancer. The programmed cell death (PD)-1/programmed cell death-ligand (PD-L) 1 pathway is also an important immunosuppression mechanism that allows cancer cells to escape host immunity. The effect of the tumor immune environment not only on immunotherapy effectiveness, but also on conventional anti-tumor therapy effectiveness and prognosis, has recently been demonstrated. Thus, improvement of the tumor immune environment is important. In other words, the tumor immune environment plays a role in the anti-tumor effects of conventional anti-tumor drugs. Moreover, immune checkpoint proteins such as PD-1, PD-L1, and PD-L2 may play an important role in improving the tumor immune environment. Given this background, the clinical significance of immune checkpoint protein expression was investigated in patients receiving neoadjuvant chemotherapy (NAC) for breast cancer using conventional anti-cancer drugs, and whether this would be useful as a marker to predict treatment response was evaluated. Experimental Design: A total of 177 patients with resectable early-stage breast cancer were treated with NAC. All patients received a standardized protocol of NAC consisting of four courses of FEC100 (500 mg/m2 fluorouracil, 100 mg/m2 epirubicin, and 500 mg/m2 cyclophosphamide) every 3 weeks, followed by 12 courses of 80 mg/m2 paclitaxel administered weekly. Forty-five patients had HER2-positive breast cancer and were additionally administered weekly (2 mg/kg) or tri-weekly (6 mg/kg) trastuzumab during paclitaxel treatment. ER, PR, HER2, Ki67, PD-L1, PDL-2 and PD-1 status were assessed by immunohistochemistry on core needle biopsy specimens. Results: There were 37 (20.9%) patients with high PD-1 expression, 42 (23.7%) patients had high PD-L1 expression, and 52 (29.4%) patients had high PD-L2 expression. The patients with high PD-1 and PD-L1 expressions had a significantly higher rate of triple-negative breast cancer (TNBC) (p=0.041) (p<0.001). Univariate analysis showed that PD-1 and PD-L1 expressions were associated with significantly shorter DFS (p=0.008, HR=2.752) (p=0.002, HR=3.194). However, although multivariate analysis showed that lymph node metastases were an independent poor prognostic factor (p=0.046, HR=4.330), PD-1 and PD-L1 expressions were not independent prognostic factors (p=0.492, HR=1.415) (p=0.084, HR=2.613). In TNBC, patients with high PD-1 and PD-L1 expressions had significantly higher rates of non-pCR (p=0.003) (p<0.001). Univariate analysis showed that PD-1 and PD-L1 expressions also significantly shortened disease free survival in TNBC (p=0.048, HR=3.318) (p=0.007, HR=8.375). However, multivariate analysis found that only PD-L1 expression was an independent prognostic factor (p=0.041, HR=9.479). Conclusions: PD-1 and PD-L1 expressions may be useful as biomarkers to predict treatment responses to NAC in breast cancer. Above all, PD-L1 expression may also be useful as biomarkers for more effective chemotherapy in TNBC. Citation Format: Asano Y, Kashiwagi S, Goto W, Morisaki T, Noda S, Takashima T, Onoda N, Hirakawa K. Prediction of treatment responses to neoadjuvant chemotherapy in triple-negative breast cancer by analysis of immune checkpoint protein expression. [abstract]. In: Proceedings of the Thirty-Eighth Annual CTRC-AACR San Antonio Breast Cancer Symposium: 2015 Dec 8-12; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2016;76(4 Suppl):Abstract nr P4-04-14. Collapse

Terasaka K, Yoshimura S, Kato Y, Furuta K, Aramaki M, Morisaki T, Tanaka MY. High-impedance wire grid method to study spatiotemporal behavior of hot electron clump generated in a plasma. Rev Sci Instrum 2014;85:113503. [PMID: 25430112 DOI: 10.1063/1.4901096] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]

Fujiyoshi T, Minatoya K, Ikeda Y, Ishibashi-Ueda H, Morisaki T, Ogino H. 329-I * IMPACT OF CYSTIC MEDIAL NECROSIS ON THE EARLY AND LATE OUTCOME OF PATIENTS WITH AORTIC DISSECTION. Interact Cardiovasc Thorac Surg 2014. [DOI: 10.1093/icvts/ivu276.329] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open

Kashiwagi S, Asano Y, Kurata K, Morisaki T, Noda S, Kawajiri H, Takashima T, Onoda N, Maeda K, Hirakawa K. Tle3 is a Useful Marker for Predicting the Therapeutic Effect of Eribulin Chemotherapy for Triple-Negative Breast Cancer. Ann Oncol 2014. [DOI: 10.1093/annonc/mdu326.7] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open

Shibata Y, Manabe T, Kajita S, Ohno N, Takagi M, Tsuchiya H, Morisaki T. Compact and high-particle-flux thermal-lithium-beam probe system for measurement of two-dimensional electron density profile. Rev Sci Instrum 2014;85:093510. [PMID: 25273729 DOI: 10.1063/1.4895718] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]

Noda S, Asano Y, Kurata K, Morisaki T, Kashiwagi S, Kawajiri H, Takashima T, Onoda N, Hirakawa K. A Pilot Study to Investigate Factors to Predict the Effect of Fulvestrant 500Mg Treatment in Postmenopausal Patients with Tam or Ai-Resistant Estrogen Receptor Positive Breast Cancer. Ann Oncol 2014. [DOI: 10.1093/annonc/mdu329.13] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open

Asano Y, Kashiwagi S, Kurata K, Morisaki T, Noda S, Kawajiri H, Takashima T, Onoda N, Maeda K, Hirakawa K. Expression and Clinical Significance of Androgen Receptor in Triple-Negative Breast Cancer. Ann Oncol 2014. [DOI: 10.1093/annonc/mdu326.9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open

Miyazawa J, Goto T, Morisaki T, Goto M, Sakamoto R, Motojima G, Peterson B, Suzuki C, Ida K, Yamada H, Sagara A. Direct extrapolation of radial profile data to a self-ignited fusion reactor based on the gyro-Bohm model. Fusion Engineering and Design 2011. [DOI: 10.1016/j.fusengdes.2011.06.008] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]

Masuzaki S, Shoji M, Tokitani M, Murase T, Kobayashi M, Morisaki T, Yonezu H, Sakamoto R, Yamada H, Komori A. Design and installation of the closed helical divertor in LHD. Fusion Engineering and Design 2010. [DOI: 10.1016/j.fusengdes.2010.08.048] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]

Hosoyamada M, Takiue Y, Morisaki H, Cheng J, Ikawa M, Okabe M, Morisaki T, Ichida K, Hosoya T, Shibasaki T. Establishment and analysis of SLC22A12 (URAT1) knockout mouse. Nucleosides Nucleotides Nucleic Acids 2010;29:314-20. [PMID: 20544513 DOI: 10.1080/15257771003738634] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]

Ida K, Inagaki S, Yoshinuma M, Tamura N, Morisaki T. Potential Structure and Transport in the Magnetic Island in LHD. Fusion Science and Technology 2010. [DOI: 10.13182/fst10-a10798] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]

Kawahata K, Peterson BJ, Akiyama T, Ashikawa N, Emoto M, Funaba H, Hamada Y, Ida K, Inagaki S, Ido T, Isobe M, Goto M, Mase A, Masuzaki S, Michael C, Morisaki T, Morita S, Muto S, Nagayama Y, Nakamura Y, Nakanishi H, Sakamoto R, Narihara K, Nishiura M, Ohdachi S, Okajima S, Osakabe M, Sakakibara S, Sanin A, Sasao M, Sato K, Shimizu A, Shoji M, Sudo S, Tamura N, Tanaka K, Toi K, Tokuzawa T, Veshchev EV, Vyacheslavov LN, Yamada I, Yoshinuma M. Overview of LHD Plasma Diagnostics. Fusion Science and Technology 2010. [DOI: 10.13182/fst10-a10819] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]

Affiliation(s)

K. Kawahata National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
B. J. Peterson National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
T. Akiyama National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
N. Ashikawa National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
M. Emoto National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
H. Funaba National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
Y. Hamada National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
K. Ida National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
S. Inagaki Kyushu University, Kasuga 816-8580, Japan
T. Ido National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
M. Isobe National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
M. Goto National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
A. Mase Kyushu University, Kasuga 816-8580, Japan
S. Masuzaki National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
C. Michael National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
T. Morisaki National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
S. Morita National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
S. Muto National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
Y. Nagayama National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
Y. Nakamura National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
H. Nakanishi National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
R. Sakamoto National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
K. Narihara National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
M. Nishiura National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
S. Ohdachi National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
S. Okajima Chubu University, Kasugai 487-8501, Japan
M. Osakabe National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
S. Sakakibara National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
A. Sanin Budkel Institute of Nuclear Physics, Novosibirsk 630090, Russia
M. Sasao Tohoku University, Sendai 980-8579, Japan
K. Sato National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
A. Shimizu National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
M. Shoji National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
S. Sudo National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
N. Tamura National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
K. Tanaka National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
K. Toi National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
T. Tokuzawa National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
E. V. Veshchev National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
L. N. Vyacheslavov Budkel Institute of Nuclear Physics, Novosibirsk 630090, Russia
I. Yamada National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
M. Yoshinuma National Institute for Fusion Science, 322-6 Oroshi-cho, Toki-shi 509-5292, Japan
LHD Experiment Group

Collapse

Yamasaki A, Onishi H, Morisaki T, Tanaka M, Katano M. Evaluation of gammadelta T cells as antigen-presenting cells for cancer immunotherapy. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.e21068] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open